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Abstract of the Dissertation

Mechanisms Underlying Memory Deficits Following West Nile Virus Neuroinvasive
Disease

by
Michael John Vasek
Doctor of Philosophy in Biology and Biomedical Sciences
Neurosciences
Washington University in St. Louis, 2015
Professor Robyn Klein, Chair

Neurocognitive sequelae are observed in >50% of patients who survive
neuroinvasive infections with encephalitic arboviruses, such as the mosquito-borne West
Nile virus (WNV)1. Early diagnosis and high survival rates from WNV neuroinvasive
disease (WNND) (>90%) have thus led cumulatively to approximately ten thousand
patients living with neurocognitive impairments2,3, with 1-3000 cases accruing yearly, yet
underlying mechanisms responsible for these deficits have not been investigated.
Within the last 15 years, studies have begun uncover many pathways which are
utilized both by the developing CNS as well as the immune system, including the use of
cytokines in the regulation of progenitor cell proliferation 4–6 and synaptic refinement via
the classical complement cascade7. Under healthy conditions, an intact blood-brainbarrier limits potential crosstalk between these domains. But amidst settings of CNS
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infection or damage, invocation of CNS developmental programs could be initiated by
proinflammatory factors. With this in mind, the chapters of this thesis are centered around
a theme of studying pathways utilized by both the immune system and the developing
CNS and determining what the consequences are for cognition and memory during CNS
West Nile virus infection.
First we have established a novel murine model of recovery from WNND in which
intracranial inoculation of the attenuated mutant WNV-NS5-E218A8,9 leads to similar CNS
viral loads and inflammation as peripheral inoculation of its parent strain, WNV-NY99,
with rates of survival and cognitive dysfunction that mirror human WNND. WNV-NS5E218A-recovered mice exhibit impaired spatial learning without significant alterations in
cortical and hippocampal volume or total neuron numbers, but exhibit persistently
activated microglia. Whole transcriptome analysis of hippocampi from WNV-NS5-E218Arecovered mice with poor spatial learning revealed increased expression of genes known
to drive microglial effects on synaptic pruning, including the classical complement
pathway and phagocytosis. Indeed, the classical complement cascade initiation factor,
C1qA, was found to be produced primarily by microglia and localized to infected neurons
and synapses during WNND. Electron and confocal microscopy revealed a loss of
hippocampal

mossy

fiber

synapses

while

synaptophysin-positive

puncta

and

phagosomes containing synaptic vesicles were observed within microglia. This loss of
mossy fiber synapses was also observed in human WNND post-mortem samples.
Importantly, mice with fewer microglia (IL34 -/-) or mice deficient in complement (C3 -/-)
were protected from WNV-induced synapse loss. This study provides a novel murine
model of WNV-induced spatial memory impairment, provides evidence that viral infection

xi

of adult neurons may induce complement-mediated elimination of synapses, and
identifies a potential mechanism underlying neurocognitive impairments experienced by
patients recovering from WNND.
Next we report that during WNND recovery, significantly fewer new granule cell
neurons are born within the hippocampal dentate gyrus, as revealed by BrdU-labeling.
And although neuronal progenitor cells (NPCs) are not direct targets of WNV infection,
their homeostatic levels of proliferation, differentiation, and migration were significantly
altered. Using immunohistochemistry and flow cytometry coupled with in vivo BrdU
labeling during acute WNV infection, we found NPCs within the subventricular (SVZ) and
subgranular (SGZ) neurogenic zones generated fewer new neuroblasts, but greater
numbers of astrocytes, an effect which slowly recovers over about 45 days. This effect
was dependent upon Interleukin-1 receptor (IL-1R) signaling, which we have previously
shown to be necessary for promotion of viral clearance by T lymphocytes10. Lastly, mice
deficient in IL-1R were resistant to the WNV-mediated impairment in spatial learning and
memory via the Barnes maze task at 45 days post infection, suggesting that alterations
to neuronal progenitor cell homeostasis could also underlie long term cognitive
consequences of WNND.

xii

CHAPTER 1 – Introduction: The effects of neuroinflammation on memory and
cognition
Nearly every disease of cognitive dysfunction presents with an underlying proinflammatory state within the central nervous system (CNS). Proper cognitive function
involves not only the correct assembly, maintenance, and function of existing neural
circuits, but also the capacity to generate or enhance new circuits. It involves one to be
able to efficiently respond to stimuli, remember past memories and associations, as well
as make new memories and associations. Mechanistically, there is an extremely intricate
and complex series of events underlying these tasks, of which new details are constantly
being discovered. And as is evidenced by the number of diseases of cognitive disability
stemming from abnormal CNS development, there are many developmental molecules
and pathways which are critical to complex cognitive functions. In this chapter, using West
Nile virus Neuroinvasive Disease (WNND) as an example, I will discuss the inflammatory
response to CNS infection, cells and molecules involved in this process, and how the
homeostatic state of the brain can be altered through invocation of several neural
development pathways which share many molecules and receptors with the immune
system.

West Nile virus and the host immune response
West Nile virus is a single-stranded, mosquito-borne, arbovirus of the genus,
flavivirus. Since WNV arrived in North America in 1999, 18,810 cases of WNV
Neuroinvasive Disease (WNND), which include cases of meningitis, encephalitis, and
acute flaccid paralysis, plus 22,952 non-neuroinvasive cases, mostly cases of which West
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Nile fever (WNF), have been reported within the United States 11. Symptoms of acute
WNND include fatigue, muscle weakness, headache, fever, coma, and about 10% of
WNND cases are fatal
million over this period

12,
13.

with an estimated cost of care totaling approximately $800

Unfortunately, for the 16,000+ survivors of WNND, about half

of patients will experience long term cognitive sequelae including, memory impairments,
parkinsonism, word-finding difficulties, confusion, depression, and weakness12,14–17. And
although the diagnosis of WNF is technically considered to exclude cases of CNS entry,
some WNF patients experience symptoms for weeks to months including headaches,
neck pain, and difficulties with concentration18, suggesting that low-level CNS infections
may occur in WNF patients as well. To date, there have been no published studies which
examine mechanistic causes of cognitive sequealae during WNND.
In studies examining post-mortem tissue from acute WNND patients, WNV has
been found within neurons of many different regions of the CNS including the frontal
cortex, hippocampus, thalamus, basal ganglia, brainstem, cerebellum, and spinal cord 19.
Fortunately, a well-established murine model of acute WNND exists and many insights
into WNV pathogenesis and the host immune response against it have been gained over
the last 15 years. WNV primarily infects neurons within the CNS20 and can induce their
apoptosis via Caspase-321.
There are several steps between the mosquito bite and CNS invasion by WNV.
And though the blood-brain-barrier is an important mechanism in CNS pathogen defense
and is able to exclude many pathogens from entry, WNV as well as several other
members of the flavivirus genus, including Japanese Encephalitis virus and St. Louis
encephalitis virus, are known for their ability cause neuroinvasive disease. First,
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mosquito-borne WNV enters the dermis and infects local Langerhans dendritic cells,
which then traffic to the lymph nodes22. At this stage, the initiation of a successful innate
immune response, including upregulation of type I and II interferons, likely prevents
further viral spread in asymptomatic or mild WNF cases23,24. But if WNV is not controlled
within the periphery, viremia develops, followed by potential invasion into the CNS 24. And
although the exact mechanism by which WNV enters the CNS is not known, especially in
human pathogenesis, several possible theories have been discussed. In response to
WNV and other neurotropic viruses, peripheral-derived cytokines such as Tumor Necrosis
Factor-α (TNFα), Interferon-γ, and Interleukin-1β may act to temporarily permeabilize the
blood brain barrier, facilitating viral entry25,26. Another hypothesis is that WNV gains CNS
entry through a “trojan horse” method27, initially brought in by an infected leukocyte,
similar to the mechanism of HIV CNS invasion. Finally, WNV has been observed to travel
along peripheral nerve axons and undergo retrograde trans-neuronal trafficking in a
sciatic nerve infection model, suggesting that spread from peripheral nerves into the
spinal cord may be another possible route of CNS entry28,29.

The complement system of pathogen defense
The complement system is a well-studied cascade of proteins involved in
recognizing and facilitating the opsinization or lysis of foreign material as well as apoptotic
cellular debris30. This process from recognition to opsinization or lysis can occur within
seconds to minutes of an invading pathogen entering the blood and is a very important
component of early immune defense. There are three potential initiating pathways, the
classical, lectin, and alternative pathways, which all converge and lead to either
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opsinization or formation of the membrane attack complex, acting to lyse the cell or
pathogen. The classical pathway is initiated by the factor C1q binding to aggregated
IgG/IgM antibodies or other moieties such as nucleic acids or amyloids, setting off a series
of zymogen activations via recruitment and cleavages of additional factors (C1r, C1s, C4,
C2, and C3)30. The Lectin pathway is initiated by mannan-binding lectin or ficolins, which
recognize carbohydrates and polysaccharides on pathogen surfaces31. The alternative
pathway relies on the spontaneous hydrolysis and activation of complement, which due
to a short half-life, would only continue amplification in the absence of endogenous
regulators and inhibitors, such as decay accelerating factor and membrane cofactor
protein (MCP)32. The alternative pathway can also act as an amplification loop for
complement activation derived from the classical and lectin pathways. All three pathways
lead to either the eventual cleavage of C3 into iC3b, which causes the particles or cells
to be recognized and engulfed by phagocytes such as macrophages and microglia, or
formation of the membrane attack complex via sequential activations of C5, C6, C7, C8,
and C9, resulting in membrane lysis33.
All three activation arms of the complement pathway can independently contribute
to anti-WNV host defense. Mice deficient in components of either the alternative,
classical, or lectin pathways show increased viral loads and enhanced mortality to WNV
in a peripheral infection model34. Additionally, mice deficient in either the lectin or classical
pathways produced lower levels of anti-WNV antibodies and had less reactive T cells34,35.
Interestingly, WNV and related flaviviruses, antagonize complement C4 activity through
binding of the virus’ non-structural protein, NS136, further suggesting a key antiviral
defense role for the complement pathway.
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Leukocytes and cytokines in anti-WNV defense
Following WNV neuro-invasion, leukocytes have been shown to play important
roles in aiding viral clearance. CD8+ T lymphocytes, especially, are indispensable in
mediating viral clearance37. CD4+ T lymphocytes38 and B cells39 are also important for
WNV clearance. Several cytokines including CXCL1040, Interleukin-1β10, Tumor Necrosis
Factor α (TNFα)41, CXCL1242,43, and CCL3-CCL544 play important roles in helping to
recruit T cells, macrophages, and other leukocytes into the CNS and across the brain
endothelium into the infected brain parenchyma.

Microglia as immune cells of the CNS
Microglia, as the resident phagocytes of the brain, are frequently in close proximity
to and involved during episodes of CNS damage or infection. They have been shown to
phagocytize viruses, bacteria, and apoptotic cellular debris in these settings 45.
Furthermore, they are potent producers of many antimicrobial molecules, such as nitric
oxide, as well as cytokines and chemokines such as Interleukin 1β, Interleukin 6, Tumor
necrosis factor alpha (TNFα), and CXCL1046. While these microglial-derived oxidative
molecules and cytokines may be instrumental in microbial defense, several studies have
pointed to neurotoxic roles for microglia, especially in neurodegenerative conditions such
as Alzheimer’s disease47. Furthermore, during Japanese Encephalitis Virus, overactivation of microglia could contribute to the observed neurotoxicity in the murine
model48.
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Neural development
The (CNS) does not instantly attain the ability to perform complex cognitive tasks
from the moment that the neural tube takes shape, but rather must follow an intricate and
prolonged series of developmental events. During neurulation, gradients of bone
morphogenic proteins, Wnts, transforming growth factor beta (TGFβ), and Homeobox
domain genes help to establish asymmetry and the basis for CNS patterning 49. This
allows for formation of ventricles and the ventricular zone immediately adjacent, where
multipotent neural stem cells (radial glia) give rise to transit-amplifying progenitors, which
in turn proliferate further in order to generate the many millions of neuroblasts, many of
which will develop into mature neurons.

Axon guidance, synaptic connections, and synaptic refinement
Following and during developmental neurogenesis, neurons from all the different
regions of the CNS begin to establish synapses with target neurons, forming circuits
which will eventually serve as the basis for cognition. During this stage and for the rest of
life, new neuronal connections can be made, unnecessary connections can be removed,
and existing connections can be strengthened or weakened50.
Proteins of the MHC class I (MHCI) complex, including MHCI, TAP and Beta 2
microglobulin, expressed by nearly all cells, are key to the immune system’s ability to
distinguish self from non-self51,52. Peptide fragments of proteins from the cell’s lysosomal
pathway are presented by the MHC complex on the cell surface for potential recognition
by T lymphocytes. Thus, when a cell is infected with a pathogen, peptide fragments of
that pathogen will be able to be presented to T cells, priming the immune system to invoke

6

a response. Interestingly, within the last 15 years it was discovered that neurons express
high levels of MHCI, usually only upregulated during infection 53, during the CNS
developmental stages of axon guidance and synapse formation/refinement 54. It was later
discovered that neurons also express an MHCI receptor, Paired Immunoglobulin-like
Receptor B (PirB), as well as the CD3ζ chain subunit of the T cell receptor, and that
expression of neuronal MHCI and its receptors was required for proper axon targeting,
synapse formation, and ocular dominance plasticity within the mammalian visual
system55–57. It is interesting that T lymphocytes and neurons, two cell types which often
undergo long distance migrations and then must identify highly specific targets, have both
adapted versions of the MHCI system for target recognition.
Earlier in this chapter, I discussed the critical role of the Complement system in
innate immune pathogen defense, which has been discovered over 100 years ago 58.
Recently in 2007, components of the classical complement cascade have been shown to
be highly expressed in the period of CNS development during which excess synapses
are pruned to promote the maintenance of efficient and synchronous neuronal circuits 7.
Deficiency in the classical complement pathway resulted in mice which were not able to
properly refine their visual system into eye-specific layers. Later, it was discovered that
microglia, through expression of the complement receptor 3 (CR3) facilitate this synaptic
pruning through recognition of C3 and iC3b deposition on neuronal synapses, and that
this process is regulated by neuronal activity59. Though the expression of CNS classical
complement components is reduced following the period of synaptic pruning, there is
evidence that the system can be restimulated during adulthood in several neurologic
disease states including Alzheimer’s Disease60,61 and Multiple Sclerosis62. The intriguing

7

scenario where the classical complement cascade is activated during adult CNS
neurotropic WNV infection will be discussed in detail in Chapter 2 of this thesis.
Several other molecules are utilized during CNS development for axon guidance
and synapse refinement which are either expressed by the immune system or are related
to immune genes. Neuronal pentraxins, which are highly related to C reactive protein and
Serum amyloid P component protein, two pattern recognition receptors of the immune
system, have also been shown to play a role in synaptic plasticity and refinement 63.
Finally, the chemokine CXCL12 and its two receptors, CXCR4 and CXCR7 regulate both
the trafficking of leukocytes across endothelial barriers64,65 as well as the proliferation5
and migration of neuronal progenitors during development66,67.

Adult neurogenesis
In mammals, the generation of new neurons completely halts in most brain regions
within a few weeks of life, but two brain regions continually generate new neurons
throughout adulthood: the dentate gyrus (DG) of the hippocampus and the subventricular
zone (SVZ), whose progenitors give rise to neuroblasts which migrate into the olfactory
bulb, a vestigial organ in humans68. Within the DG, adult neural stem cells can give rise
to progenitors which will eventually generate either astrocytes or neurons 69, and within
the SVZ neural stem cells can additionally give rise to oligodendrocyte precursors 70.
Within both zones, along the neuronal lineage, rapidly dividing transit-amplifying
progenitors (also known as “intermediate progenitors”) give rise to neuroblasts, which
begin to migrate to their target areas. Once neuroblasts arrive at their correct layers, the
olfactory bulb for SVZ-derived neuroblasts, and the granule cell layer for DG-derived
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neuroblasts, they either gradually integrate into the neuronal circuit or become
apoptotic71. And although the extent of the functional contribution of adult-born neurons
is not precisely known within this relatively young field, it is known that mice whose adult
neurogenesis is severely impacted, for example via radiation, suffer impairments in
certain spatial learning and memory tasks72, as well as fear-associated memory tasks73.
Furthermore, tasks such as environmental enrichment and voluntary running, which boost
cognitive performance also increase rates of adult neurogenesis71. Because newborn
neurons display a period of enhanced excitability as they integrate into the neuronal
network, it is speculated that this could add an additional layer of contextual memory
enhancement, especially within the DG74.
Of interest, neural stem and progenitor cells seem to be particularly affected by
cytokines in settings of damage or infection (reviewed in

75).

During CNS development,

such conditions can have drastic consequences, but also during adulthood, within the two
regions of adult neurogenesis (only the hippocampus in humans), changes to progenitor
cell proliferation, migratory patterns, and cell-fate differentiation could affect cognition.
How SVZ and DG adult neurogenesis are affected during the immediate acute phase as
well as the recovery phase following West Nile neuroinvasive infection will be the focus
of chapter 3 of this thesis.

Microglia during development and in healthy conditions
Although roles for microglia within tumor models, CNS damage, and infections
have been documented for over a century76,77, only within the last 5-10 years have we
begun to understand microglia’s function in the healthy brain. Microglia arise from early
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myeloid progenitors during the yolk-sac stage of development, which migrate into the
CNS before a blood-brain-barrier has been established and represent a distinct lineage
from circulating monocytes78. Thus, they are present during the very early stages of CNS
development and indeed play critical roles during this time. Microglia act as important
sources of growth factors such as basic fibroblast growth factor for neural progenitors and
promoting survival of neurons79. Microglia also phagocytize ventricular zone neuronal
progenitors during the end stages of embryonic cortical neurogenesis 80, presumably to
help limit the genesis of new precursors and neurons once enough neurons have been
generated. Following neurogenesis, microglia also act to induce apoptosis of excess
neurons81,82. Within the hippocampus, this process has been shown to require Dap12 and
CD11b, which along with CD18, comprises Complement Receptor 383. Interestingly,
mutations in either Dap12 or TREM2, two proteins which are only expressed within the
CNS by microglia, in humans can cause a loss of function inherited dementia termed
nasu-hakola disease84. Of interest, both Dap12 and TREM2 are involved in the regulation
of phagocytosis by microglia and Dap12 can affect synaptic function 85. These studies
suggest that in order for proper cognitive functioning to occur and be maintained, the
phagocytic activity of microglia must remain intact.
As previously discussed, microglia mediate the pruning of synapses via
complement during normal CNS development59. This process has been shown to be
necessary for proper brain development and function 86. Furthermore, depletion of
microglia during development using diphtheria toxin in a CX3CR1-DTR murine model
causes impairments in multiple learning tasks87. Microglia are now known to contribute to
synapse maintenance during healthy adulthood and have been shown to constantly
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monitor and contact nearby synapses, in addition to their roles during development88.
Aiding in this process, microglia express the receptor, CX3CR1, which recognizes the
ligand, CX3CL1, which is expressed by neurons45. Indeed, murine deficiency in CX3CR1
lead to impairments in spatial learning and synaptic plasticity89.
It should not be surprising that microglia, which are responsible both for the
maintenance and refinement of synapses under healthy conditions, as well as
antimicrobial functions such as cytokine release and phagocytosis during CNS
inflammatory

conditions,

are

deeply

entwined

in

studies

on

the

effect

of

neuroinflammation on cognition. This is especially of interest when groups of molecules
like the Complement proteins mediate the opsinization and phagocytosis of both
synapses and pathogens, during normal CNS development and inflammatory conditions,
respectively. This dual role of microglia will be investigated and discussed in chapter 2.
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CHAPTER 2 - A complement-microglial axis is required for synapse elimination
during virus-induced memory impairment

This chapter is derived from the following manuscript

A complement-microglial axis is required for synapse elimination during virusinduced memory impairment

Michael J. Vasek1, Charise Garber1, Denise Dorsey1, Tony Sun1, Bryan Bollman1,
Douglas Durrant1, Jinsheng Yu2, Carlos Perez-Torres3, Arnaud Frouin4, Daniel Wilton4,
Xiaoping Jiang5, Steven Mennerick5, John Robinson6, Kenneth L. Tyler8, Joel Garbow3,
Robert E. Schmidt7, Beth Stevens5, and Robyn S. Klein1,7,9

Departments of 1Medicine, 2Genetics, 3Radiology, 5Psychiatry, 7Pathology and
Immunology, 8Anatomy and Neurobiology, Washington University School of Medicine,
St Louis MO 63110
Department of 4Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital,
Harvard Medical School, Boston, MA 02115
Department of 6Integrative Neuroscience, Stonybrook University, Stony Brook, NY
11794
Department of 8Neurology, University of Colorado School of Medicine, Aurora, CO
80045
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Abstract
Neurocognitive sequelae are observed in >50% of patients who survive neuroinvasive
infections with encephalitic arboviruses, such as the mosquito-borne West Nile virus
(WNV)1. Early diagnosis and high survival rates from WNV neuroinvasive disease
(WNND) (>90%) have thus led cumulatively to approximately ten thousand patients living
with neurocognitive impairments2,3, with 1-3000 cases accruing yearly, yet underlying
mechanisms responsible for these deficits have not been investigated. Here, we
established a novel murine model of recovery from WNND in which intracranial
inoculation of the attenuated mutant WNV-NS5-E218A8,9 leads to similar CNS viral loads
and inflammation as peripheral inoculation of its parent strain, WNV-NY99, with rates of
survival and cognitive dysfunction that mirror human WNND. WNV-NS5-E218Arecovered mice exhibit impaired spatial learning without significant alterations in cortical
and hippocampal volume or total neuron numbers, but exhibit persistently activated
microglia. Whole transcriptome analysis of hippocampi from WNV-NS5-E218A-recovered
mice with poor spatial learning revealed increased expression of genes known to drive
microglial effects on synaptic pruning, including the classical complement pathway and
phagocytosis. Indeed, the classical complement cascade initiation factor, C1qA, was
found to be produced primarily by microglia and localized to infected neurons and
synapses during WNND. Electron and confocal microscopy revealed a loss of
hippocampal

mossy

fiber

synapses

while

synaptophysin-positive

puncta

and

phagosomes containing synaptic vesicles were observed within microglia. This loss of
mossy fiber synapses was also observed in human WNND post-mortem samples.
Importantly, mice with fewer microglia (IL34 -/-) or mice deficient in complement (C3 -/-)
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were protected from WNV-induced synapse loss. Our study provides a novel murine
model of WNV-induced spatial memory impairment, provides evidence that viral infection
of adult neurons may induce complement-mediated elimination of synapses, and
identifies a potential mechanism underlying neurocognitive impairments experienced by
patients recovering from WNND.

Introduction
In 2003, WNV produced the largest encephalitic arbovirus epidemic within the USA
on record (9,862 cases) and continually resurges every year 2,90. Since its emergence in
North America in 1999, rodent models have yielded insights into the neuropathogenesis
of WNV, demonstrating critical roles for innate and adaptive immune responses in
controlling peripheral infection and neuroinvasion24. WNV is capable of infecting neurons
within several CNS regions including the basal ganglia, brain stem, cerebellum, cortex,
hippocampus, and spinal cord19,23,40,91,92. In human post-mortem WNND patient samples
and in rodent models with low survival rates (<50%), significant neuronal loss, leukocyte
infiltration, and microglial activation occur within infected brain regions10,21,43,93, however,
the extent and location of viral burden and neuronal loss may be significantly different
within the >90% of patients who survive the acute phase of WNND. Moderate viral
burdens, variations in the locations of infection, and differential host-pathogen interactions
could explain the diverse array of cognitive sequelae experienced by WNND survivors,
which includes memory impairment, parkinsonism, confusion, and ataxia 12,94. Studies in
humans and rodents indicate that cortical structures such as the hippocampus are among
the highly targeted areas of infection19, and patient survivors of both WNND and West
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Nile Fever (WNF), a flu-like illness that occurs in 20% of cases95, often suffer from
impairments to visuospatial processing and memory96,97. The hippocampus is essential
for spatial and contextual memory formation via a trisynaptic circuit between the
entorhinal cortex and the dentate gyrus, CA3, and CA1 regions of the hippocampal
formation98. Damage to hippocampal neurons, their synaptic connections, or alterations
in expression of critical gene pathways could restrict proper spatial memory formation or
memory recall.
Microglia, the only resident myeloid cell type within the CNS parenchyma, exhibit
critical roles in immune defense, antigen presentation, and as phagocytes within the
virally infected CNS99,100. Recent studies in mice have additionally highlighted important
roles for microglia in the development and maintenance of proper neuronal synapses59,88.
Mice deficient in CX3CR1 – CX3CL1 signaling, which are expressed by microglia and
neurons within the CNS, respectively, exhibit impaired developmental synaptic
pruning101, impaired spatial learning and memory89, and reduced hippocampal long term
potentiation (LTP)89. Recently, studies have shown that the proteins C1q and C3,
members of the classical complement cascade which assist in the opsonization of
pathogens and apoptotic debris, are necessary for the pruning of weak retinothalamic
and cortical synapses during murine CNS development 7,102. Microglia recognize and
phagocytize synaptic elements through their expression of complement receptor CR3,
which recognizes C359. The classical complement system is activated and contributes to
control of WNV dissemination following peripheral WNV infection 34, but whether
complement is induced within the brain during WNND has not been investigated. It is
unknown how microglia manage their dual roles in pathogen recognition/clearance and
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synaptic modeling and how complex brain processes such as learning and memory may
be affected as a result of viral infection of the CNS.

Results
The neuropathogenesis of cognitive impairments in patients recovering from
WNND or WNF are unknown, in large part due to lack of good murine recovery models.
Current murine models that utilize WNV-99 (NY isolate 1999) yield either 100% death
following i.c. WNV infection41 or 10-70% survival and variable CNS viral burdens following
peripheral routes of infection, depending on the age of the mice103,104. While hamster
models show better survival and are therefore more amenable to spatial learning tasks,
they lack the attractive genetic approaches available for murine models105. To circumvent
this, we utilized a strain of WNV with a point mutation in nonstructural protein 5 (WNVNS5-E218A), which lacks functional 2′-O methyltransferase, an enzyme which generates
a 5’ cap on viral RNA to evade type I interferon-mediated restriction of viral translation8,106
to develop a novel model of recovery from WNND for evaluation of spatial learning. While
this mutation does not prevent replication in permissive cells, we previously reported that
90% of 8 week-old mice survive an i.c. inoculation (104 pfu) (Fig. 2.S1a), resulting in
uniform viral brain burdens that peak between 6-8 days post infection (dpi)9, with near
complete viral clearance from the brain at 15 dpi (Fig. 2.S1b-c), although positive sense
(non-replicating strand) viral RNA may be detected by quantitative PCR in low levels (510 copies per 10000 copies of GapDH) for weeks as previously described for WNVNY00107, RNA from the replicating, negative sense strand, of WNV was completely absent
at 25 and 52 days post-infection, providing evidence against any persistent CNS WNV
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infection in our model (Fig. 2.S2a). Mice i.c. infected with WNV-NS5-E218A develop a
robust CNS inflammatory response within 7 dpi, with numbers of infiltrating leukocytes,
lymphocytes, macrophages and microglia not significantly different from those observed
during i.c. infection of WNV-NY99 (Fig. 2.S1d), consistent with prior data demonstrating
early reversion of WNV-NS5-E218A to wild-type virus within the CNS9. Acute WNV-NS5E218A i.c. infection resulted in low, but measurable numbers of apoptotic neurons (0.5 –
1.5%) at 7 dpi (Fig. 2.S1e) numbers comparable to that observed in 8 week-old mice after
f.p. infection with WNV-NY9921. These data indicate that WNV-NS5-E218A may be used
as a model to examine behavioral, cellular, and molecular mechanisms of CNS recovery
from WNND.
To determine whether WNV-NS5-E218A-recovered mice exhibit neurocognitive
disturbances, 8 week-old, infected mice were permitted to recover for over a month p.i.
(45 dpi), followed by assessment of their ability to spatially locate and remember the
location of a target hole over the course of 5 consecutive days of testing on the Barnes
maze behavioral task108. On average, mice recovering from WNV encephalitis exhibit a
significantly slower learning curve than mock-infected controls, committing more errors
(Fig. 2.1a; p = 0.0008 by two-way repeated measures ANOVA) and requiring significantly
more time (Fig. 2.1b; p = 0.016 by two-way repeated measures ANOVA) before locating
the target hole on days 2-5 of testing (data not shown). WNV recovered animals
eventually learn the task, although they continue to make more errors than mock-infected
controls, even after 5 days of learning. Of note, recovered animals do not exhibit any
impairments in activity or exploratory anxiety as assessed through number of lines
crossed or center crosses, respectively, in an open field behavioral assessment at 45

17

days p.i. (Fig. 2.1c-d), indicating that impairments in solving the Barnes maze are specific
to spatial learning deficits.
Prior studies reported that WNV may trigger caspase-3-dependent apoptosis in
infected

neurons

of

animals

that

succumb

to

WNND21.

Quantitative

immunohistochemistry did not detect ongoing apoptosis (Fig. 2.S2b) or significant loss of
NeuN+ neurons within the dentate gyrus, hippocampal CA1, hippocampal CA3,
entorhinal/perirhinal cortex, and visual cortex, regions associated with learning and
memory (Fig. 2.S2c). Similarly, volumetric brain analysis at 52 dpi, as assessed by MRI,
revealed no difference in hippocampal or total brain volume in mock- versus WNV-NS5E218A-recovered animals (Fig. 2.S2d). While immunofluorescent studies revealed an
increase in reactive astrocytes within the cortex in WNV-NS5-E218A- versus mockinfected animals (data not shown), this was not observed within the hippocampus (Fig.
2.S3a). However, microglial nodules within several brain regions, including the
hippocampus, were detected via standard histology (arrowhead in Fig. 2.S3b) and WNVrecovered animals exhibited significantly increased levels of the microglial and
macrophage activation markers, IBA1 (Fig. 2.1e) at 7, 25, and 52 dpi, and CD68 (Fig.
2.1f-g) at 7 dpi. Colocalization of CD68 staining in CX3CR1-GFP heterozygous mice
shows CD68 upregulation both on microglia (CX3CR1-GFP-positive; white arrowheads)
and on infiltrating macrophages (red arrowheads) at 7 dpi with WNV-NS5-E218A (Fig.
2.1f).
Microglia have been shown to exhibit distinct transcriptomic signatures, expressing
a unique cluster of transcripts that encode proteins involved in sensing endogenous
ligands and microbes (microglial sensome)109. To identify molecular mechanisms that
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underlie memory dysfunction in our WNV-recovered animals, we performed wholetranscriptome microarray to compare RNA transcripts differentially expressed in mockversus WNV-NS5-E218A-infected mice at 25 dpi, a time-point at which infectious virus is
cleared and animals display spatial learning defects. Profiling total RNA from the
hippocampi of mock- versus WNV-NS5-E218A-infected mice revealed differential
expression of 1364 transcripts (p<0.05, FC > 1.5) between mock versus WNV-NS5E218A-recovered animals (Table 2.S1). Pathway analyses of these genes identified
genetic signatures associated with a variety of neural correlates of spatial memory,
including the generation and maintenance of synapses and neurogenesis, especially
those involving activation of innate immune responses and the microglial sensome (Table
2.S2). In the latter category, we identified genes associated with microglial-mediated
phagocytosis (CX3CR1, Dap12, FcγR1G, FcγR2, Rac2, WAS) and the classical
complement pathway (C1qA, C2, C3, C4b, Serping1) (Fig. 2.2a), which were validated
via quantitative (Q)PCR (Fig. 2.2b).
To identify gene expression signatures specifically associated with spatial learning
defects, we took advantage of individual variability in spatial learning performance
displayed by WNV-NS5-E218A-recovered animals, categorizing WNV-NS5-E218Ainfected mice into those that perform similar to mock-infected animals (good learners –
fewer than 8 errors) and those that exhibit severe learning deficits (poor learners – greater
than 10 errors), based on Barnes maze results on the second day of testing (Fig. 2.2ce). Categorization of mice into good versus poor learners revealed 747 genes that were
significantly increased in the WNV-poor learners, 45 genes altered in WNV-good learners,
and 572 genes altered in both groups compared to mock-infected littermates (Fig. 2.2f)
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(Table 2.S3). Prior studies indicate that intraparenchymal lymphocytes, especially CD8+
T cells, persist in the CNS after recovery from WNND110. Consistent with this, many of
the genes identified encoded proteins associated with innate and adaptive immunity
including interferon-stimulated genes (ISGs), cytokines, chemokines and many
immunoglobulin domains. Because lymphocytes have been shown to drive microglial
activation111–113, we examined microglial sensome and synapse genes in additional
cohorts of WNV-NS5-E218A-recovered good and poor learners following Barnes maze
screening. QPCR evaluation of hippocampi derived from WNV-NS5-E218A-recovered

increased levels of C1qA and decreased levels of Dlg2 and Grm5 are especially
associated with poor spatial learning (Fig. 2.2g). Prior studies have shown that Dap12,
114–117.

Serping1 and CRRY, inhibitors of the classical complement cascade, are known to be
expressed in the setting of complement-mediated tissue loss in mice118,119. C1qA has
been shown to be involved in synaptic pruning during development 7 and in certain disease
models including multiples sclerosis62 and spinal cord injury120. Dlg2 acts as a synaptic
scaffolding protein involved in complex learning121, whereas Grm5 and Grin1 are
components of metabotropic and ionotropic glutamate receptors, respectively – each
shown to contribute to hippocampal plasticity122,123 and have been previously found to be
downregulated in mouse brain during acute phases of WNV, Japanese Encephalitis virus,
and Reovirus infections124. KEGG pathway analyses of genes differentially altered (fold
change > 1.5 and p < 0.05) between WNV-good vs. WNV-poor mice reveal cytokine
signaling, calcium signaling, and B-cell receptor signaling among the top pathways found
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to be upregulated in WNV-poor mice (Table S4), whereas downregulated pathways
included LTP, axon guidance, and wnt signaling (Table S5). As all WNV-infected mice in
our study exhibit inflammation during viral clearance, which is equivalent in good and poor
learners (Fig. 2.2h), these differentially expressed genes suggest that poor spatial
learners exhibit alterations in pathways specifically tied to cognitive function.
Given the alterations in genes relating to synaptic function we evaluated synapse
numbers within the hippocampus of WNV-NS5-E218A-infected mice. Quantitation of
synaptophysin-positive puncta within the stratum lucidum of the hippocampal CA3 (mossy
fiber synapses) detected a 25% reduction in presynaptic terminals during the peak of viral
brain titers in WNV-NS5-E218A-infected animals compared to mock-infected, age and
sex-matched controls (Fig. 2.3a). Importantly, mice i.c. or f.p. inoculated with wild-type
WNV (WNV-NY99) showed similar reductions in synapse numbers to the WNV-NS5E218A mutant strain during peak infection (Fig. 2.4a). Of interest, synapses from mice
with fewer and less proliferative microglia (IL34 -/-)125, however, were not significantly
altered during WNV-NS5-E218A acute infection (Fig. 2.3a). In wild type animals,
evidence of hippocampal synapse loss continued to be detectable out to 25 days postinfection where WNV-NS5-E218A-recovered mice with severe spatial learning
impairments (WNV-poor) had significantly fewer VGlut1-positive synapses than their
WNV-NS5-E218A-infected littermates with intact spatial learning (WNV-good), which had
fewer synapses than mock-infected controls (Fig. 2.3b).
Colocalization studies also observe synaptophysin-positive puncta within GFP+
cells of WNV-NS5-E218A-infected CX3CR1GFP heterozygous mice (Fig. 2.3c), best
observed via 3-dimensional reconstruction using confocal microscopy (data not shown),
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demonstrating that resident microglia are pruning synapses. Immunohistochemistry and
quantification of colocalization between IBA1 and synaptophysin reveal significantly
increased numbers of microglia-engulfed presynaptic terminals in the hippocampal CA3
from WNV-NS5-E218A-infected mice at days 7 and 25 post-infection (Fig. 2.3d). By
contrast, WNV-NS5-E218A did not induce any increase in astrocyte colocalization with
synapses (Fig 2.S4b). Electron microscopy of the CA3 and molecular layer of the
hippocampus (Fig 2.3e) during acute WNND confirm this synapse loss and identify
microglia that are greatly enriched in phagosomes, including phagosomes containing
40nm synaptic vesicles (red arrowheads) and those observed extending processes that
surround synapses (Fig. 2.3ei), which is rarely seen in mock-infected controls. Moreover,
quantitation of synaptophysin-positive puncta within acute post-mortem WNND patient
specimens showed significantly reduced hippocampal CA3 synapse numbers compared
to age-matched patient controls (median age for each cohort = 62.6 years, n = 5 WNV
cases and 8 control cases) (Table 2.6) (Fig 2.3e). Of note, synapse numbers within the
CA3 of WNND patients under 60 years old were comparable to levels observed from
control patients 20-30 years older (Fig 2.3e). In 3 out of 5 WNV cases, West Nile virus
antigen could be detected within the hippocampal CA2/CA3 region, but West Nile antigen
was mostly absent from other neighboring regions (Dentate Gyrus: 0/5, CA1: 0/5 cases,
Entorhinal Cortex: 1/5 cases) (Table S6 and Fig 2.S5a). Quantification of synaptophysinpositive area within the hippocampal CA1 and entorhinal cortex in the human patient
samples displayed synapse reduction that was not significant (p = 0.1), (Fig. 2.S5 b, c).
As macrophage-mediated phagocytosis is often accompanied by antibody and
complement deposition in the periphery in order to enhance opsinization of dying cells

22

and pathogens, we next sought out to determine if either or both components of this
pathway were necessary for WNV-mediated synaptic pruning.

Double-label

immunohistochemistry for endogenous mouse IgG and the presynaptic marker, VGlut1,
revealed no differences in the amount of endogenous mouse IgG coating VGlut1-positive
hippocampal CA3 synapses at both 7 and 25 dpi following WNV-NS5-E218A compared
to mock-infected controls (Fig. 2.S6a). Furthermore, WNV-NS5-E218A-infected B celldeficient mice (µMT-/-) exhibited similar levels of synapse loss within the hippocampus as
infected wild-type mice (data not shown), confirming that B cells and antibodies are not
necessary for WNV-mediated synapse reduction.
Based on our microarray results identifying WNV-induced alterations in the
classical complement cascade and prior studies delineating a role for complement in
microglial synaptic pruning during development7,59, we next determined if complement
might mediate the microglial phagocytosis of synapses during WNV infection.
Hippocampal upregulation of the initiating factor of the classical complement cascade,
C1qA, was detected by quantitative RT-PCR at days 7, 25, and 52 p.i. compared to mockinfected age-matched controls (Fig 2.4a). To identify cellular sources of C1qA, we
performed in situ hybridization using RNA probes for C1qA together with antibodies to
neuron specific enolase (NSE) and IBA1. IBA1-positive cells were the main producers of
hippocampal C1qA mRNA, both in mock-infected and WNV-NS5-E218A-infected mice,
which showed increased levels (Fig 2.4b). Within IBA1+ cells, C1qA mRNA expression
can commonly be seen within processes adjacent to or surrounding neurons (insets:
arrowhead in Fig 2.4b). Double-label immunohistochemistry confirmed co-localization of
C1qA with IBA1 (Fig 2.4c, white arrowheads), however, as C1qA is a secreted protein,
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much of the C1qA staining appears in extracellular spaces surrounding IBA1+ cells.
Within WNV-NS5-E218A-infected mice at 7dpi, C1qA can be found within the
hippocampal CA3 colocalized within WNV antigen-positive infected neurons (Fig 2.4d)
and with VGlut1-positive presynaptic terminals in greater levels than mock-infected
controls (Fig 2.4e-f). To determine if complement was necessary for WNV-mediated
hippocampal synapse pruning, we examined synapse loss at 7 days post-infection in
mock- versus WNV-NS5-E218A-infected C3-/- littermate mice and found equivalent
numbers of synaptophysin-positive puncta in both groups (Fig 2.4g), indicating that WNVmediated synapse elimination requires complement C3, the converging point of the
complement pathways.

Discussion
Multiple studies, better diagnoses, and greater numbers of survivors of WNND
over the last 10 years have begun to highlight the prevalence of cognitive impairments in
this population, however there is little cellular and molecular understanding of these
impairments14,15,97,126. Using a novel murine model to study memory impairments during
recovery from WNND, we show that mice exhibit spatial learning and memory deficits
during recovery and robust microglial activation during the acute phase that persists for
nearly two months post-WNV infection. Using electron and confocal microscopy, we
demonstrate that these activated microglia phagocytize synapses during the peak of
WNV infection, leading to a significant loss of synapses in the hippocampus and
entorhinal cortex. Using whole transcriptome array approaches we identified genes and
pathways associated with poor spatial learning, including molecules involved in
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microglial- and complement-mediated phagocytosis of synapses. Consistent with these
data, we observed upregulation of complement protein C1q within neurons and microglia
and showed that CA3 synapse elimination is abolished in mice deficient in either microglia
or complement C3. Moreover, we detected significantly reduced numbers of hippocampal
CA3 synapses in post-mortem specimens from human cases of WNV encephalitis
compared with age- and sex-matched controls, highlighting the relevancy of our murine
model for human infections with WNV. Our study is the first to show synapse elimination
as a pathological feature of WNV encephalitis and to delineate mechanisms that underlie
this elimination.
The ability of WNV to infect and kill neurons has been well-described in human
cases of WNV encephalitis127 and in rodents lethally infected with WNV-NY99128,
however, infection with attenuated WNV-NS5-E218A induces spatial learning and
memory deficits, despite lack of neuron loss during peak infection (Fig. 2.S1e) or at one
month post-clearance (Fig 2.S2b). These data suggest that significant neuron loss is not
required for deficits in cognitive function. Consistent with this, WNF patients also report
cognitive impairments for months following infection18, suggesting that low levels of CNS
viral burden that do not lead to overt encephalitis may be capable of affecting cognition
through disruptions in the network of synapses in the absence of neuron loss.
Complement, which has a well-described role in coating apoptotic cells and cellular
debris for opsonization, has recently been implicated in synapse elimination by
microglia7,59. Many pathogens and pathogen-associated molecular patterns have been
shown to induce complement activation within the CNS, including WNV35, HIV129, amyloid
plaques130, and prion proteins131. CNS cell types, including neurons, astrocytes, and
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microglia can express complement components, including C1q130. Persistence of viral
nucleic acid or intraparenchymal migration of macrophages that harbor viral antigen may
promote microglial and complement activation via pathogen recognition 132–136. Microglialmediated synapse modulation has been observed in mice both during development 7 as
well as in adult animal models of Alzheimer’s Disease and Parkinson’s disease, both
shown to be dependent on Complement C3 and its receptor, CR3137,138. Our model of
WNV-mediated synaptic pruning is similar in this regard to these cases of synaptic
pruning, in that it also requires complement C3. Although synapses are labeled by
complement C1qA and lost during WNV infection, it is unknown whether these synapses
are connected to healthy neurons, infected neurons, or a mixture of the two. In situ
hybridization identified microglia as the prominent source of complement C1qA (Fig.
2.4b), but other cellular sources of C1q as well as the other members (C1qB, C1qC, C1r,
C1s, C2, C4, C3) of the classical cascade have not been examined. Of note, animals
deficient in complement C3 are more susceptible to WNV-NY99 and show higher CNS
viral burdens, however this susceptibility occurs via loss of virologic control in the
periphery35. Whether complement C3 might also affect other neurobiological processes
during CNS viral infections is unknown.
Over the past 5-10 years there has been significant debate over the pathogenicity
of microglia139,140. Important studies have begun to describe the critical role of microglia
and key molecules they express under normal, healthy CNS conditions for proper
neuronal circuit formation and memory function101,89. But under neuropathologic
conditions, as resident phagocytes and major sources of cytokines141, they are almost
always observed within areas of CNS injury and inflammation, and thus often considered
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guilty by association. Recent work, however, points to several neuroprotective roles for
microglia during neuroinflammation including the displacement of inhibitory synapses to
aid in neuronal survival during inflammation142 and increased monitoring of synapses
during ischemic injury88. In our model of WNV encephalitis and recovery, microglia are
clearly involved in pruning (glutamatergic) mossy fiber synapses, which is linked to the
deficits in spatial memory performance as evidenced by transcriptional profiling (Fig.
2.2g) and to greater synapse elimination in WNV-infected mice with poor spatial memory
(Fig 2.3b). However, in the setting of a neurotropic viral infection, elimination of synapses
may be advantageous for the prevention of transsynaptic viral spread or to prevent
infected neurons from issuing excitotoxic signals. Indeed, retrograde and anterograde
spread of WNV has been observed within peripheral neurons28. Several other neurotropic
viruses, including Rabies virus and Herpes Simplex virus (HSV) types 1 and 2, are well
known for their ability to gain CNS access via peripheral nerves and subsequent
retrograde, transsynaptic spread into CNS neurons143,144. Of interest, HSV-1 produces
glycoprotein C, a protein which binds and antagonizes complement C3 145, which may
allow it to travel through networks of neurons undetected. In the setting of neurotropic
viral infection, loss of synapses, which readily regenerate, may be preferable to significant
neuronal loss. Further studies are warranted to determine if the complement-dependent,
microglial, synaptic pruning pathway is capable of preventing neuron-to-neuron spread of
WNV and other neurotropic viruses.
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Methods
Animals
8-10 week-old male and female mice were used at the outset of all experiments.
C57BL/6J mice were obtained from Jackson Laboratories. C3 -/- mice (> 10 generations
backcrossed to C57Bl/6) were obtained from Dr. John Atkinson (Washington University),
CX3CR1-GFP +/- mice (>10 generations backcrossed to C57Bl/6) were obtained from
Dr. Richard Ransohoff (Lerner Research Institute, Cleveland Clinic Foundation), µMT -/mice (C57Bl/6 background) were obtained from Dr. Michael Diamond (Washington
University), and IL-34 -/- mice (C57Bl/6 background) were obtained from Dr. Marco
Colonna (Washington University). All experimental protocols were performed in
compliance with the Washington University School of Medicine Animal Safety Committee
(protocol# 20140122).

Mouse models of WNV infection
Footpad: (WNV-NY99) The WNV strain 3000.0259 was isolated in New York in 2000146
and passaged once in C6/36 Aedes albopictus cells to generate an insect cell–derived
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stock. 100 plaque forming units (pfu) of WNV-NY99 were delivered in 50 uL to the footpad
of anaesthetized mice.

Intracranial: “WNV-NS5-E218A,” which harbors a single point mutation in the 2’O-methyltransferase gene, was obtained from Dr. Michael Diamond (Washington University) and
passaged in vero cells as described previously8. Deeply anaesthetized mice were
administered 104 pfu of WNV-NS5-E218A or 10 pfu of WNV-NY99 in 10 uL into the brain’s
third ventricle via a guided 29 gauge needle.

Stock titers of all viruses were determined by using BHK21 cells for viral plaque assay as
previously described39.

Leukocyte isolation and flow cytometry
Cells were isolated from brains of WT mice at day 7 post-infection and stained with
fluorescently conjugated antibodies to CD4, CD8, CD11b, and CD45 as previously
described10. Data collection and analysis were performed with an LSRII flow cytometer
using FlowJo software.

Behavioral Testing
Test for anxiety and locomotor behavior
The Open Field Test was used to assess for baseline differences in anxiety or locomotor
behavior, prior to Barnes Maze experiments. A standard Open Field arena
(21.25”x21.25”, custom built) was used, consisting of a simple square box with a grid (6
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squares/side) along the base. Animals were placed in the center of the arena and allowed
to explore for 5 minutes. The arena was decontaminated with 70% ethanol between each
trial. Locomotor activity was assessed by counting the number of lines the animal crossed
during the testing period, and anxiety was assessed by counting the number of times the
animal crossed through the center of the field. Behavior was recorded using a camera
(Canon PowerShot SD1100 IS), and a blinded experimenter scored the trial.
Test for visual spatial memory
The Barnes Maze was used to assess for visual spatial memory. An elevated Barnes
Maze (36” diameter, custom built) containing 19 empty holes and 1 target hole with a
hidden escape chamber was used for testing (2” diameter holes were evenly spaced
around the table, 2.5” from the edge). Visual cues were placed around the room and
remained in the same location during the entire testing period. Mice were tested on the
Barnes Maze over the course of 5 consecutive days. Each mouse received two trials per
day, spaced exactly 30 minutes apart. For each trial, the mouse was placed in the center
of the maze in a covered start box for 10 seconds, and removal of the box signaled the
start of a trial. Each mouse was given 3 minutes to explore the maze and find the target
hole. Mice that did not enter the target hole within 3 minutes were gently guided into the
hole. After each trial, the mouse remained in the target hole for exactly 1 minute, and then
was returned to its home cage. The maze was decontaminated with 70% ethanol between
each trial. The numbers of errors (nose pokes over non-target holes) and the latency to
find the target hole (amount of time elapsed before nose poke over target hole) were
measured. Behavior was recorded using a camera (Canon Powershot SD1100IS), and a
blinded experimenter scored the trials.
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Immunohistochemistry
Following perfusion with ice-cold PBS and 4% PFA, brains were immersion-fixed
overnight in 4% PFA, followed by cryoprotection in 2 exchanges of 30% sucrose for 72
hours, then frozen in OCT (Fisher). 9µm-thick fixed-frozen coronal brain sections were
washed with PBS and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich), and
nonspecific Ab was blocked with 5-10% normal goat serum (Santa Cruz Biotechnology)
for 1 h at room temperature. Mouse on Mouse kit (MOM basic kit, Vector) was used per
manufacturers protocol when detecting synaptophysin (mouse, DAKO) to reduce
endogenous mouse Ab staining. After block, slides were exposed to primary Ab or isotype
matched IgG overnight at 4°C, washed with 0.2% FSG in PBS and incubated with
secondary Abs for 1 h at room temperature. Nuclei were counterstained with ToPro3
(Invitrogen) and coverslips were applied with vectashield (Vector). Immunofluorescence
was analyzed using a Zeiss LSM 510 laser-scanning confocal microscope and
accompanying software (Zeiss). Positive immunofluorescent signals were quantified
using the public domain NIH Image analysis software, ImageJ.

TUNEL staining was performed using the TMR-red in situ cell death detection kit (Roche)
as per manufacturer’s instructions. C1qA staining was performed as previously
described147.
For synaptophysin staining, the mouse-on-mouse blocking kit (Vector Labs) was used as
per manufacturer’s protocol.
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Antibodies
C1qa (Undiluted, described previously in147,148), WNV (1:100 described previously

10),

GFAP (1:200 Invitrogen), IBA1 (1:100), IBA1 (for immuno-EM), MAP2 (1:100, Millipore),
NeuN-biotin (1:100. Millipore), GFP (1:1000 Abcam), Synapsin-1 (1:200, Millipore),
Synaptophysin (1:50. DAKO)

Secondary antibodies conjugated to Alexa-488, Alexa-555, or Alexa-633 (Invitrogen)
were used at 1:400 dilution.

MRI
Mice were intracardially perfused, first with ice-cold PBS and then with a mixture of 4%
PFA and 10% Multihance (gadobenate dimeglumine, Bracco Diagnostics Inc, Princeton,
NJ). Heads were further fixed in 4% PFA for 24 hours before being trimmed of extraneous
tissue around the skull (to minimize the field of view). Heads were then placed in 1%
Multihance in PBS until being imaged several days later. Ex vivo, whole-head MR imaging
experiments were performed at 4.7 T using an Agilent/Varian (Santa Clara, CA)
DirectDrive1 small-animal scanner. Data were collected with a custom-made RF foil coil
that fit tightly around the head using a 3D, T1-weighted gradient echo sequence with the
following parameters: TR = 105 ms, TE = 6 ms, flip angle = 90º, isotropic resolution =
0.0625 mm, and scan time ~11 hrs. Regions of interest were manually drawn for the
whole brain and hippocampus in ITK-SNAP (www.itksnap.org) from which volumes were
calculated.
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Harvest and purification of hippocampal RNA
Mice were perfused with ice-cold PBS then hippocampi were dissected and snap-frozen
in Tri-reagent (Ambion). Hippocampal tissue was then homogenized, and RNA purified
as previously described149 using the RNA Ribopure kit (Ambion). RNA was precipitated
with 25 mM Ammonium Acetate in 100% EtOH at -80 °C overnight, resuspended in
RNAse-free H2O, and checked for purity. RNA was then treated with RNAse-out and
DNAse I (invitrogen) as per manufacturer’s protocol.

Microarray
Hippocampal RNA was isolated as above and submitted to the Washington University
Genome Technology Access Center. The total RNA quality and quantity were then
determined by Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA) and
NanoDrop ND-1000 Spectrophotometer (Thermo Scientific NanoDrop, Wilmington, DE),
according to manufacturer’s recommendations, respectively. A total of 400 ng of RNA
transcripts from each sample were amplified by T7 linear amplification with the
MessageAmp TotalPrep Amplification kit (Life Technologies-Ambion, Austin, TX). Then
1.5 µg of each amplified and biotinylated RNA (aRNA) sample was hybridized onto
Illumina MouseWG-6 v2 Expression Beadchips, followed by cy3 steptavidin–based
staining, washing, and scanning, according to Illumina standard protocol. The iScan
scanner-created image data were loaded into Illumina GenomeStudio (v2011) for
generation of expression values and data normalizations. Only those probes that were
detected at p<0.05 in at least one of the samples were kept in downstream statistical
analysis. Background subtracted and quantile normalized data were used in statistical
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analysis for identification of differentially expressed genes with one-way ANOVA test
using Partek Genomics Suite (v6.6, St. Louis, MO). All original p-values in the ANOVA
analysis were adjusted by q-value based multiple test correction150. KEGG pathway
analysis was performed using DAVID bioinformatics database functional annotation tool
v.6.7 151.

Real-time quantitative RT-PCR
cDNA was synthesized using random hexamers, oligodT15, and MultiScribe reverse
transcriptase (Applied Biosystems). A single reverse transcription master mix was used
to reverse transcribe all samples in order to minimize differences in reverse transcription
efficiency. The following conditions were used for reverse transcription: 25°C for 10 min,
48°C for 30 min, and 95°C for 5 min.

For calculation of WNV-E protein (positive and negative strand), Taqman primer-probes
were used and copies were calculated based on a standard curve generated from a WNVE protein plasmid as previously described9. For all other primer sets, PCR reactions were
prepared using Power SYBR Green PCR mastermix. Calculated copies were normalized
against copies of the housekeeping gene, GAPDH.

Quantification of synapses
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ImageJ was used to threshold confocal images, draw region of interest encompassing
the CA3 mossy fibers, and quantify either percent area of synaptophysin staining or
number of synaptophysin+ puncta between 0.5 and 5 square microns in area.

Electron microscopy
Mice were perfused with 4% PFA, the brain was removed, and immersion fixed for 24
hours at RT. Tissue was washed in PBS, and 100µm sections were cut from regions of
interest using a vibratome. Sections were incubated in 0.5% gelatin, 5% horse serum,
and 0.01% saponin in PBS for 5 hours on a rotator at RT. Sections were then incubated
for 48 hours at 4°C on rotator with rabbit anti-Iba1 (1:600; Wako). After washing in dPBS,
sections were incubated overnight at 4°C on rotator with donkey anti-rabbit biotinylated
secondary antibody, (1:500; Rockland) in 0.5% gelatin and 5% horse serum in dPBS.
Sections were again washed, and then incubated with streptavidin-HRP (1:1000;
Rockland, S000-03) for 3 hours at RT, followed by another wash. HRP was visualized
using the DAB Substrate Kit (Cell Marque,957D) for 5 minutes, washed and then fixed
with 2%PFA, 2.5% glutaraldehyde, in PBS for 30 mins, followed by a wash in PBS.
Sections were post-fixed in 1% osmium tetroxide in PBS for 30 minutes at RT, washed in
PBS, and then dehydrated in sequential concentrations of ethanol for 30 minutes each.
Sections were then infiltrated with 1:1 Spurr’s resin and 100% ethanol overnight on a
rotator, followed by two changes in pure Spurr’s resin over 24 hours. Sections were
embedded with Aclar film (EMS, 50425), and polymerized at 60°C for 48 hours. The
hippocampus was trimmed from the polymerized section, glued to a previously prepared
block of Spurr’s resin, and allowed to cure for at least 24 hours. Using a Diatome ultra
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45° diamond knife and a LEICA Ultracut UC7, blocks were sectioned at 500nm to confirm
location of the tissue and the positivity of antibodies. Once confirmed, 90nm sections
were cut and picked up onto 200 hex mesh, formvar-carbon coated copper grids (Ted
Pella, 01800-F). Images were digitally captured using a JEOL 1200 EX II Transmission
Electron Microscope with AMT digital camera.

Three-dimensional reconstruction of confocal Z-stack images
Confocal Z-stack images taken with a Zeiss LSM 510 META microscope at 63x
magnification, consisting of at least 10 images were transformed into 3-D reconstruction
movies using Volocity 3D image analysis software (PerkinElmer).

Super-resolution microscopy of presynaptic terminals
9 micron fixed-frozen sections were stained for the glutamatergic presynaptic marker,
VGlut1 and complement C1qA. Z-stack images were then taken using a Zeiss superresolution microscope and projection images were generated using Zeiss Zen analysis
software.

Human Tissue
Human autopsy hippocampal tissue embedded in paraffin was obtained from St. Louis
University Medical Center (St. Louis, MO) and Presbyterian / St. Luke’s Medical Center
(Denver, CO). Sections were first deparaffinized and then boiled in sodium citrate buffer
for antigen retrieval before staining with anti-synaptophysin antibody (DAKO, 1:50)
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In situ Hybridization
Fluorescent in situ hybridization was performed on 9um coronal brain sections which were
4% PFA-fixed and frozen. C1qA and NSE was used as double mRNA staining and Iba1
as immune-staining. C1qA and NSE anti-sense RNA was made and labeled with cyanine
and fluorescein, respectively, using an RNA labeling kit (Roche). C1qA was synthesized
from pCMV SPORT6 C1qA plasmid from Openbiosystem reference # MMM1013-63584
(which was digested with SalI and transcribed with T7 Promoter). The RNA probes were
incubated over night at 64 degree Celsius, and then detected with antibodies against
fluorescein and cyanine (Roche). The staining reaction was then amplified with a TSA
staining Kit (PerkinElmer). A Rabbit anti-Iba1 (Wako) was used to label the microglia and
detected with a Donkey anti Rabbit 647 (Life technologies). Stained sections were then
imaged and analyzed on a Zeiss AX10 fluorescent microscope.

Statistical analysis
Results from Barnes Maze spatial learning and memory studies were compared by
repeated measures two-way ANOVA. Microarray data was analyzed by one-way ANOVA
and fold change greater than 1.5, false discovery rate q < 0.05 to correct for multiple
hypotheses for Mock vs. WNV-all comparison, p < 0.05 for WNV-good vs WNV-poor. All
other experiments compared by student’s two-tailed T-test, with * p < 0.05 considered as
significant.
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Figure 2.1 Spatial learning and memory impairments and activated microglia
persist beyond one month post-infection. (a) At days 46-50 post WNV-NS5-E218A or
mock-infection, WNV-infected mice commit more errors (nose poke in non-target hole) in
the Barnes Maze spatial learning and memory task and take more time (b) before finding
the target hole as measured in the average of two trials per day for 5 days (*** p < 0.001,
* p <0.05 by repeated measures two-way ANOVA). At 45 days post-infection (p.i.), mice
were observed for 2 minutes on the open-field test and were found to be equivalent to
mock-infected controls both in locomotor activity (c) and in exploratory anxiety (d), as
measured by center crosses. (e) Immunohistochemistry for IBA1 and Topro3 (nuclear)
reveals persistent microglial activation within the hippocampal dentate gyrus and CA3 of
WNV-NS5-E218A-infected mice at 7, 25, and 52 days p.i. compared to age-matched
mock-infected controls (mean of 2 experiments). Scale bar = 50 µm. (f) Representative
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images from immunohistochemistry for CD68 within the hippocampal CA3 at 7 days postmock or WNV-NS5-E218A infection in CX3CR1-GFP heterozygous mice shows
increased CD68 staining both within CX3CR1-positive microglia (white arrowheads) as
well as in CX3CR1-negative infiltrating macrophages (red arrowheads) (scalebar = 10
µm). (g) Representative images and quantification of CD68 staining at day 7 post mock
or WNV-NS5-E218A infection in wild type mice (scalebar = 10 µm).*** p < 0.001, * p <
0.05, by Student’s two-tailed T-test
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Figure 2.2 Transcriptional expression profile of good and poor spatial learners
during WNV recovery. (a) Heatmaps showing relative expression of significantly altered
genes (FDR q < 0.05, FC > 1.5) generated from a hippocampal microarray analysis of
mock vs. WNV-NS5-E218A-recovered mice at 25 days post-infection. (b) Validation of
select genes and pathways in unique set of mice by quantitative PCR. (c) Scatter plot
depicting number of errors on day 2 of Barnes Maze testing, the most sensitive learning
period, showing good and poor learners among the WNV-NS5-E218A recovery group.
(d) PCA plots from the microarray analysis shows unique transcriptional expression
profiles among mock-infected controls and good and poor learners recovering from WNVNS5-E218A.(e) Relative expression heatmap from microarray of the top 50 upregulated
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and 50 downregulated (by fold change) genes comparing WNV-recovery good and poor
learners. (f) Venn diagram of microarray data showing number of genes significantly
altered from mock-infected controls (p < 0.05, FC > 1.5) which are unique or shared
among WNV-recovery good or poor learners. (g) Validation by quantitative PCR of select
genes significantly altered between WNV-good and WNV-poor learners using a unique
set of mice (n = 3-6 mice per group). (h) Copies of positive-strand (non-replicating strand)
mRNA for the WNV envelope protein present at day 25 post-infection show no difference
in amount of persistent positive-strand viral RNA between good and poor learners. *** p
< 0.001, ** p < 0.01, * p < 0.05 by Two-tailed student’s T-test.
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Figure 2.3 WNV causes a loss in hippocampal CA3 synapses in mice and humans.
(a) Immunohistochemistry for the presynaptic marker, synaptophysin, reveals a reduction
in hippocampal CA3 synapses at 7 days post-infection in wildtype mice infected with
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WNV-NS5-E218A compared to age-matched mock-infected controls, but IL34 -/- mice
infected with WNV-NS5-E218A do not show any significant loss of synapses compared
to mock-infected controls. Scalebar = 10 µm. (b) Immunohistochemistry for the
glutamatergic presynaptic marker, Vglut1, reveals a reduction in CA3 synapses which
persists to 25 days post-infection and is most severe in WNV-infected mice who perform
poorly on the Barnes Maze spatial memory task. Scalebar = 10 µm. (c)
Immunohistochemistry for synaptophysin and GFP within CX3CR1-GFP +/- mice, used
as a marker of microglia, show multiple synaptophysin+ puncta localized within microglial
cytoplasm. Scalebar = 10 µm. (d) Immunohistochemistry for synaptophysin and IBA1
within the hippocampal CA3 reveals a greater percentage of synaptophysin+ area
colocalized within IBA1+ microglia in WNV-NS5-E218A-infected WT mice at 7 and 25
days post-infection. Lower-left panel depicts engulfed synapses (magenta to white
gradient scale based on colocalization) within IBA1+ cells including a high-power inset.
Scalebar = 20 µm. (e) At day 7 post WNV-NS5-E218A infection, electron microscopy with
immune-DAB

staining

for

the

microglia/macrophage

marker,

IBA1,

reveals

morphologically distinct IBA1-positive cells often possessing phagosomes which contain
40nm synaptic vesicles (red arrowheads in e and ei) and which have processes that
surround nearby synapses (ei). Scalebars = 1 µm.(f) Immunohistochemistry for
synaptophysin within human autopsy cases shows that acute WNV encephalitis patients
show significant reductions in hippocampal CA3 synaptophysin+ area compared to age
and sex-matched controls. Scalebar = 10 µm. * p < 0.05 by Two-tailed student’s T-test.
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Figure 2.4 Classical complement cascade in neurons and microglia controls WNVmediated synapse elimination. (a) Hippocampal mRNA levels of C1qA are upregulated
at days 7, 25, and 52 post WNV-NS5-E218A infection. (b) Fluorescent in situ hybridization
shows upregulation of C1qA mRNA within IBA1-positive cells at 7 days post infection with
WNV-NS5-E218A. scalebar = 50 µms (c) Immunohistochemistry reveals colocalization
(white arrowheads) between C1qA protein and the microglial/macrophage marker, IBA1.
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Immunohistochemistry for C1qA protein shows C1qA deposition on WNV antigen-positive
(infected) neurons at 7 d.p.i. (d) and on VGlut1-positive synapses 7 and 25 d.p.i. (e:
confocal

with

quantification

&

f:

super-resolution

microscopy

images).

(g)

Immunohistochemistry for the presynaptic terminal marker, synaptophysin, in
complement C3-null mice at 7 days post infection reveals that C3-null mice are resistant
to WNV-NS5-E218A-mediated synapse loss within the mossy fiber region of the
hippocampal CA3. Synapse numbers quantified as number of 0.5 – 25 sq. µm
synaptophysin+ puncta per mm2, normalized to age-matched mock-infected controls. **
p < 0.01, * p < 0.05 by student’s two-tailed t-test.
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Figure 2.S1. Murine intracranial infection with attenuated WNV-NS5-E218A induces
similar viral loads and inflammatory response as wildtype WNV-NY99, but greater
overall survival. (a) Plaque assay performed on dissected brain tissue at various time
points post-infection (p.i.) with either footpad (FP) infection with 102 pfu of WNV-NY99 or
intracranial (IC) infection with 104 pfu WNV-NS5-E218A shows peak titers (plaque
forming units per gram of tissue) of WNV-NS5-E218A at 6 days p.i., which are cleared
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from the hippocampus by 15 days p.i. (b) Survival curve of mice infected at 8 weeks old
via the FP with WNV-NY99 or IC with WNV-NY99 or WNV-NS5-E218A. (c-d) Flow
cytometric analysis of dissected cortex, hippocampus (plots for CD45 and CD11b shown
in c) and cerebellum at 6 days p.i. with WNV-NY99 and WNV-NS5-E218A show similar
increases (d) in numbers of leukocytes (CD45-high), lymphocytes (CD45-high, CD11blow), and activated macrophages and microglia (CD45-high, CD11b-high) compared to
mock-infected controls (n = 4 mice per group). (e) Immunohistochemistry and counts for
TUNEL staining with the neuronal marker, NeuN, during peak infection (day 7) reveals
small, but non-significant increases in numbers of TUNEL+ NeuN+ cells in WNV-NS5E218A (n=5) compared to mock-infected controls (n = 4) (DG = Dentate Gyrus - pictured,
CTX = Entorhinal, Perirhinal, and Visual Cortex). Two-tailed student’s t-test used to
determine significance (p < 0.05).
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Figure 2.S2. At >50 days post-WNV-NS5-E218A infection, mice do not show any
appreciable loss in brain volume or neuron numbers. (a) QPCR for positive strand
(non-replicating strand) WNV Envelope protein message remaining in hippocampal tissue
at 7, 25, and 52 days post-infection (d.p.i) (n = 3-5 mice per group). (b)
Immunohistochemistry and counts for hippocampal TUNEL staining with the neuronal
marker, NeuN, at 52 d.p.i shows that there are equivalent levels of NeuN+ and total
apoptotic cells in Mock compared to WNV-NS5-E218A (n=5) compared to mock-infected
controls (n = 3) (scalebar = 20 µm). (c) Immunohistochemistry and quantification of
number of NeuN+ neurons within the Dentate Gyrus and width of the granule cell layer at
52 days post-mock (n=4) or WNV-NS5-E218A (n=5) infection (scalebar = 100 µm). (d)
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Post-mortem mouse brains were imaged by MRI at 52 days post-infection to determine
tissue volume of the hippocampus (outlined in red) and total brain (n = 5 mice per group)
(scalebar = 1 mm). Student’s two-tailed T-test was used to determine significance of
experiments (* p < 0.05).
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Figure 2.S3. Following recovery from WNV-NS5-E218A infection, mice do not show
gross pathological differences or astrocyte activation. (a) Immunohistochemistry for
the reactive astrocyte marker, GFAP, shows that WNV-NS5-E218A-infected mice do not
exhibit greater hippocampal astrocyte activation than mock-infected controls at 52 days
post-infection. (b) H&E staining shows intact hippocampal CA1 pyramidal cell layer, and
occasional microglial nodules (arrowhead) surrounded by several lymphocytes at 52 days
post-infection in WNV-NS5-E218Arecovered mice. (c) During acute WNV-NS5-E218A
infection (day 7), there is no increase in engulfment of synaptophysin+ puncta by S100β+
astrocytes as quantified by percent of synapses colabeled with S100β in the hippocampal
CA3 (Not significant by student’s t-test).
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Figure

2.S4.

Acute

synapse

loss

during

infection

with

WNV-NY99

(a)

Immunohistochemistry for the presynaptic marker, Synapsin1 within the hippocampal
CA3 reveals a significant reduction in CA3 synapses during acute wild type (WNV-NY)
footpad infection (day 8 post-infection) (b) During acute WNV-NS5-E218A infection (day
7), there is no change in hippocampal colocalization of synaptophysin+ puncta with
S100β+ astrocytes as quantified by percent of synapses colabeled with S100β (Not
significant by student’s t-test).
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Figure 2.S5. WNV infection of human hippocampal CA2/CA3 neurons with loss of
synapses within the hippocampal CA1 and the Entorhinal Cortex. (a) H&E staining
(top) and WNV-antigen immunohistochemistry (bottom) show WNV-antigen located
within CA2/CA3 pyramidal cell neuron cell bodies (arrows) and neurites (arrowheads). (b,
c) Immunohistochemistry for synaptophysin within human autopsy cases shows that
acute WNV encephalitis patients show trends towards reductions in synaptophysin+ area
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within the hippocampal CA1 (b) and entorhinal cortex (c) compared to age and sexmatched controls (scalebar = 20 µm). Note: In 1 WNV encephalitis patient sample, the
entorhinal cortex was not able to be quantified. Significance determined by two-tailed
student’s two-tailed t-test (not significant).
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Figure 2.S6. No differences in endogenous mouse IgG within the hippocampal CA3
region at 25 days post infection with WNV-NS5-E218A. No significant differences
(Student’s Two-tailed T-test, all comparisons) were detected between groups (Mock,
WNV-good, and WNV-poor learners) from immunohistochemistry and quantifications of
total endogenous mouse IgG or mouse IgG colocalization with the post-synaptic marker,
Homer1.
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gene
s

p- val

Adj
p-val

Systemic lupus
erythematosus

23

1.9E-14

0.000

Antigen
processing and
presentation

20

2.0E-12

0.000

Allograft rejection

14

2.9E-09

0.000

26

6.2E-09

0.000

18

2.2E-08

0.000

Viral myocarditis

16

2.4E-08

0.000

Autoimmune
thyroid disease

14

4.8E-08

0.000

Chemokine
signaling pathway

21

7.4E-08

0.000

Graft-versus-host
disease

12

3.2E-07

0.000

Primary
immunodeficiency

10

3.2E-07

0.000

IGHG, CD8B1, CD3D, CD3E, TAP2, TAP1, TNFRSF13B, LCK, IL2RG,
IGH-VJ558

Cell adhesion
molecules (CAMs)

18

7.1E-07

0.000

H2-K1, CD8B1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q8, VCAM1, CD86,
H2-OA, CD274, H2-EB1, CD2, H2-T10, CD6, H2-DMA, SELPLG

Type I diabetes
mellitus

12

7.7E-07

0.000

H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, CD86, H2-OA,
H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA

1.3E-06

0.000

PIK3CG, PTPN6, IFITM1, CD72, VAV1, IGHG, FCGR2B, RAC2, PLCG2,
PIK3AP1, CD79B, INPP5D, IGH-VJ558

10

1.2E-05

0.000

Toll-like receptor
signaling pathway

13

1.3E-05

0.000

PIK3CG, TLR2, CXCL9, CCL5, TLR6, STAT1, CCL4, CXCL10, CD86,
MYD88, IRF5, IRF7, CASP8

Hematopoietic cell
lineage

12

1.4E-05

0.000

CD3G, CD8B1, CD3D, CD3E, CD9, IGHG, H2-EB1, CD2, CSF3R, H2-AA,
IGH-VJ558, CSF1R

Asthma

8

2.3E-05

0.000

IGHG, H2-OA, H2-EB1, H2-AA, FCER1G, H2-AB1, H2-DMA, IGH-VJ558

Cytosolic DNAsensing pathway

8

6.5E-04

0.004

DDX58, IRF7, TREX1, CCL5, CASP1, CCL4, CXCL10, ADAR

Fc gamma Rmediated
phagocytosis

10

1.3E-03

0.007

PIK3CG, IGHG, RAC2, FCGR2B, PLCG2, INPP5D, WAS, PRKCD, VAV1,
IGH-VJ558

Fc epsilon RI
signaling pathway

9

1.6E-03

0.009

PIK3CG, IGHG, RAC2, PLCG2, FCER1G, INPP5D, PRKCD, VAV1, IGHVJ558

Complement and
coagulation
cascades

8

4.0E-03

0.021

C1QA, VWF, C1QB, C4A, C4B, SERPING1, C2, PROS1, C1QC

Jak-STAT
signaling pathway

11

8.1E-03

0.040

IRF9, PIK3CG, PTPN6, IL10RA, IL21R, CSF3R, IL2RG, STAT1, CISH,
IFNGR1, STAT2

Pathway

Cytokine-cytokine
receptor
interaction
Natural killer cell
mediated
cytotoxicity

B cell receptor
signaling pathway
Intestinal immune
network for IgA
production

13

Select Genes within pathway
HIST1H4M, HIST1H2AD, GRIN2B, HIST1H4A, C2, HIST1H4I, C4A, C4B,
FCGR4, H2-AB1, TRIM21, FCGR3, C1QA, IGHG, CD86, FCGR2B, H2DMA
H2-K1, CD8B1, H2-M3, H2-D1, IFI30, H2-AB1, CTSS, H2-Q6, H2-Q7,
CD74, B2M, TAPBP, H2-OA, PSME1, TAP2, TAP1, H2-EB1, H2-AA, H2T23,
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, IGHG, CD86, H2OA, H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA, IGH-VJ558
CCL2, IL21R, CXCL9, CXCR3, CCL5, TNFRSF4, CCL7, CXCL10,
IL10RA, TNFRSF18, CSF3R, IL2RG, IFNGR1, CD27, CSF1R, TGFBR2,
CCL19
H2-K1, PIK3CG, PTPN6, CD244, H2-D1, FCGR4, VAV1, HCST, FCGR3,
IGHG, RAC2, LCK, PLCG2, FCER1G, H2-T23, IFNGR1, IGH-VJ558,
SH3BP2
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, IGHG, CD86,
RAC2, H2-OA, CASP8, H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, IGHG, CD86, H2OA, H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA, IGH-VJ558
PIK3CG, CCL2, ADCY7, CXCL9, CXCR3, STAT1, CCL5, CCL4, VAV1,
PRKCD, WAS, CCL7, STAT2, CXCL10, RAC2, CCR5, CXCL13, CXCL16,
CX3CR1
H2-K1, H2-M3, H2-D1, H2-AB1, H2-Q6, H2-Q7, H2-Q8, CD86, H2-OA,
H2-EB1, H2-AA, H2-T23, H2-T10, H2-DMA

IGHG, CD86, TNFSF13B, H2-OA, LOC641240, TNFRSF13B, H2-EB1,
H2-AA, H2-AB1, H2-DMA, IGH-VJ558

Table 2.S1 – Pathway analysis of genes altered by WNV-NS5-E218A compared to
mock-infected controls at 25 days post-infection. KEGG pathway analysis using
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DAVID bioinformatics database functional annotation tool v.6.7. Analysis generated with
list of genes having greater than 1.5 fold change and false discovery rate q value of less
than 0.05 in Mock vs. WNV-all analysis. Adjusted p-values determined by Benjamini false
discovery rate.
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Rank

Gene

Definition

Fold ch

p

1

LOC636875

PREDICTED: similar to Ig kappa chain V-V region L7 precursor (LOC636875)

8.68

0.037

2

LOC100046552

PREDICTED: similar to Unknown (protein for MGC:103328) (LOC100046552)

7.81

0.043

3

IGHG

PREDICTED: Immunoglobulin heavy chain (gamma polypeptide) (Ighg)

6.91

0.004

4

IGH-VJ558

5.99

0.013

5

LOC381774

5.79

0.036

6

IGK-V5

PREDICTED: immunoglobulin kappa chain variable 5 (V5 family) (Igk-V5)

5.51

0.042

7

IGK-V5

PREDICTED: immunoglobulin kappa chain variable 5 (V5 family) (Igk-V5)

5.46

0.010

8

LOC207685

PREDICTED: hypothetical protein LOC207685, transcript variant 1 (LOC207685)

4.75

0.018

9

IGH-VJ558

PREDICTED: immunoglobulin heavy chain (J558 family) (Igh-VJ558)

4.71

0.016

10

LOC100047316

PREDICTED: similar to anti-MOG Z12 variable light chain (LOC100047316)

4.15

0.007

11

AI324046

4.00

0.035

12

AI324046

3.98

0.041

13

LOC386520

3.80

0.006

14

IGHV1S119_L33961_IG_HEAVY_VARIABLE_1S119_14

3.78

0.020

15

AI324046

3.57

0.019

16

LOC380801

3.53

0.011

17

LOC385109

3.47

0.018

18

SAA3

serum amyloid A 3 (Saa3)

3.46

0.046

19

LOC100047162

PREDICTED: similar to immunoglobulin kappa-chain (LOC100047162)

3.33

0.033

20

LOC640696

PREDICTED: similar to Ig heavy chain V-I region V35 precursor (LOC640696)

3.29

0.032

21

LOC636752

PREDICTED: similar to Ig kappa chain V-VI region NQ2-6.1 (LOC636752)

3.28

0.002

22

AI324046

3.26

0.042

23

IGLC2_J00595_IG_LAMBDA_CONSTANT_2_14

3.14

0.006

24

LOC669053

PREDICTED: similar to Ig kappa chain V-V region MPC11 precursor (LOC669053)

3.04

0.034

25

LOC630302

PREDICTED: similar to VH283 protein (LOC630302)

3.00

0.037

26

IGHG

PREDICTED: Immunoglobulin heavy chain (gamma polypeptide), transcript variant 1 (Ighg)

2.97

0.030

27

LOC100048770

PREDICTED: similar to Ig H-chain V-JH1-region (LOC100048770)

2.96

0.020

28

IGHV1S133_AF304553_IG_HEAVY_VARIABLE_1S133_89

2.93

0.001

29

GBP2

guanylate binding protein 2 (Gbp2)

2.84

0.037

30

SLPI

secretory leukocyte peptidase inhibitor (Slpi)

2.77

0.035

31

LOC385277

2.71

0.026

32

SERPING1

serine peptidise inhibitor 1 (C1 inhibitor)

2.68

0.043

33

UBD

ubiquitin D (Ubd)

2.52

0.046

34

IGHV1S59_L17134_IG_HEAVY_VARIABLE_1S59_150

2.46

0.008

35

LOC383196

2.44

0.002

36

IGKV4-71_AJ231218_IG_KAPPA_VARIABLE_4-71_20

2.38

0.017

37

1110059M19RIK

2.37

0.040

38

LOC383196

PREDICTED: hypothetical LOC383196 (LOC383196)

2.37

0.001

39

LOC100042270

PREDICTED: similar to Unknown (protein for MGC:41421) (LOC100042270)

2.30

0.001

40

DISP2

dispatched homolog 2 (Drosophila) (Disp2)

2.27

0.008

41

TSPO

translocator protein (Tspo)

2.26

0.026

42

IFITM1

interferon induced transmembrane protein 1 (Ifitm1)

2.25

0.013

43

PSMB8

2.25

0.036

44

CD274

2.20

0.039

45

TUBA6

2.17

0.041

46

IGHV1S30_X02462_IG_HEAVY_VARIABLE_1S30_12

2.16

0.046

47

IGKV4-91_AJ231229_IG_KAPPA_VARIABLE_4-91_29

2.13

0.033

48

CXCL10

chemokine (C-X-C motif) ligand 10 (Cxcl10)

2.12

0.045

49

PIK3AP1

phosphoinositide-3-kinase adaptor protein 1 (Pik3ap1)

2.10

0.044

50

H2-T10

histocompatibility 2, T region locus 10 (H2-T10)

2.10

0.039

51

IGHV1S34_X02467_IG_HEAVY_VARIABLE_1S34_71

2.10

0.050

52

MVP

major vault protein (Mvp)

2.09

0.039

53

CYTIP

cytohesin 1 interacting protein (Cytip)

2.09

0.025

54

PRG4

2.06

0.033

PREDICTED: hypothetical LOC383196 (LOC383196)

CD274 antigen (Cd274)

57

55

LOC434609

2.05

0.001

56

CD52

2.04

0.030

57

EGR2

2.03

0.025

58

IGHA_J00475$V00785_IG_HEAVY_CONSTANT_ALPHA_135

2.02

0.001

59

TSPO

translocator protein (Tspo)

1.99

0.030

60

SULF1

sulfatase 1 (Sulf1)

1.96

0.037

61

4930533K18RIK

1.93

0.006

62

2810046M22RIK

1.91

0.041

63

LY6C1

lymphocyte antigen 6 complex, locus C1 (Ly6c1)

1.89

0.037

64

CDKN1A

cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a)

1.89

0.046

65

HDC

histidine decarboxylase (Hdc)

1.88

0.013

66

GIMAP6

GTPase, IMAP family member 6 (Gimap6)

1.86

0.013

67

VAMP8

vesicle-associated membrane protein 8 (Vamp8)

1.85

0.022

68

TCEA3

1.83

0.015

69

LCK

1.83

0.031

70

MIA1

1.82

0.044

71

GM1276

PREDICTED: gene model 1276, (NCBI) (Gm1276)

1.82

0.047

72

IFITM1

interferon induced transmembrane protein 1 (Ifitm1)

1.81

0.038

73

TRAF1

1.81

0.021

74

IGHV1S12_J00507_IG_HEAVY_VARIABLE_1S12_239

1.81

0.001

75

H2-DMA

histocompatibility 2, class II, locus DMa (H2-DMa)

1.81

0.047

76

LOC100048556

PREDICTED: similar to monocyte chemoattractant protein-5, (LOC100048556)

1.80

0.039

77

SYNPO

1.80

0.030

78

TNF

tumor necrosis factor (Tnf)

1.78

0.037

79

LOC100048556

PREDICTED: similar to monocyte chemoattractant protein-5, (LOC100048556)

1.78

0.023

80

TAPBP

1.78

0.005

81

LOC223672

1.77

0.041

82

SELL

1.75

0.043

83

1700024G13RIK

1.73

0.003

84

LBP

lipopolysaccharide binding protein (Lbp)

1.73

0.040

85

NFKBIA

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia)

1.72

0.042

86

LOC100038882

PREDICTED: hypothetical protein LOC100038882 (LOC100038882)

1.72

0.031

87

IL1A

interleukin 1 alpha (Il1a)

1.72

0.015

88

ECM1

extracellular matrix protein 1 (Ecm1)

1.69

0.048

89

MIA1

melanoma inhibitory activity 1 (Mia1)

1.69

0.031

90

ONECUT3

one cut domain, family member 3 (Onecut3)

1.69

0.040

91

TRIOBP

1.68

0.045

92

CPT1A

1.68

0.014

93

INPP5D

inositol polyphosphate-5-phosphatase D (Inpp5d)

1.68

0.047

94

LOC100040402

PREDICTED: hypothetical protein LOC100040402 (LOC100040402)

1.67

0.039

95

TAP2

transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (Tap2)

1.67

0.028

96

2600011C06RIK

1.65

0.044

97

TNFSF13B

1.65

0.044

98

B930097J01RIK

1.64

0.027

99

TNFRSF12A

tumor necrosis factor receptor superfamily, member 12a (Tnfrsf12a)

1.64

0.040

LASS2

LAG1 homolog, ceramide synthase 2 (Lass2)

1.64

0.004

100

PREDICTED: similar to Ig heavy chain V region VH558 A1/A4 precursor (LOC434609)

lymphocyte protein tyrosine kinase (Lck)

selectin, lymphocyte (Sell)

tumor necrosis factor (ligand) superfamily, member 13b (Tnfsf13b)

Table 2.S2 – Transcriptionally altered genes by microarray, WNV-poor higher than
WNV-Good. Genes higher in WNV-poor than in WNV-good (top 100 genes by fold
change and p value <0.05)
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Ran
k

Gene

Fold ch

p

2.49

0.019

cytoplasmic FMR1 interacting protein 2 (Cyfip2)

1.97

0.000

PHD finger protein 14 (Phf14)

1.95

0.009

1.86

0.009

expressed sequence AU021092 (AU021092)

1.82

0.002

PPAP2A

phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2

1.78

0.013

7

ROCK2

Rho-associated coiled-coil containing protein kinase 2 (Rock2)

1.78

0.002

8

TRMT2B

TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae) (Trmt2b)

1.74

0.006

9

CHRNA1

cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) (Chrna1)

1.73

0.000

10

SQLE

squalene epoxidase (Sqle)

1.73

0.021

11

TTC30A1

tetratricopeptide repeat domain 30A1 (Ttc30a1)

1.72

0.004

12

SC4MOL

sterol-C4-methyl oxidase-like (Sc4mol)

1.69

0.046

13

2610044O15RIK

RIKEN cDNA 2610044O15 gene (2610044O15Rik)

1.68

0.013

14

GPR155

G protein-coupled receptor 155 (Gpr155) XM_921852 XM_921857

1.65

0.019

15

CCDC25

coiled-coil domain containing 25 (Ccdc25)

1.65

0.001

16

WDR17

WD repeat domain 17 (Wdr17)

1.65

0.042

17

PDGFRL

platelet-derived growth factor receptor-like (Pdgfrl)

1.65

0.023

18

RLBP1L1

retinaldehyde binding protein 1-like 1 (Rlbp1l1)

1.65

0.000

19

B230107J06RIK

1.63

0.003

20

LOC382964

1.63

0.020

21

STX3

syntaxin 3 (Stx3), transcript variant B

1.63

0.005

22

CYB561D2

cytochrome b-561 domain containing 2 (Cyb561d2)

1.63

0.012

23

PDIK1L

PDLIM1 interacting kinase 1 like (Pdik1l)

1.63

0.001

24

RASL12

RAS-like, family 12 (Rasl12)

1.63

0.004

25

LOC100046855

PREDICTED: similar to BKLF (LOC100046855)

1.63

0.001

26

6430531H12RIK

1.63

0.003

27

TESC

1.62

0.018

28

4631422C13RIK

PREDICTED: RIKEN cDNA 4631422C13 gene (4631422C13Rik)

1.62

0.015

29

UBE3A

ubiquitin protein ligase E3A (Ube3a), transcript variant 2

1.61

0.030

30

GUCY2E

1.61

0.005

31

DOC2B

double C2, beta (Doc2b)

1.60

0.035

32

ARHGEF9

CDC42 guanine nucleotide exchange factor (GEF) 9 (Arhgef9)

1.60

0.016

33

CCNJL

cyclin J-like (Ccnjl)

1.58

0.001

34

SEMA6C

sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (Sema6c)

1.58

0.029

35

TPPP

tubulin polymerization promoting protein (Tppp)

1.58

0.005

36

DOCK9

dedicator of cytokinesis 9 (Dock9), transcript variant 1

1.58

0.012

37

4921521J11RIK

1.58

0.026

38

GRIN1

glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1)

1.57

0.025

39

SIAH1B

seven in absentia 1B (Siah1b)

1.57

0.043

40

ALDH3A2

1.57

0.010

41

A430010E21RIK

1.56

0.007

42

DOC2B

double C2, beta (Doc2b)

1.56

0.014

43

TERF2IP

telomeric repeat binding factor 2, interacting protein (Terf2ip)

1.56

0.029

44

TCF20

transcription factor 20 (Tcf20)

1.56

0.022

45

KLRB1B

killer cell lectin-like receptor subfamily B member 1B (Klrb1b)

1.56

0.020

46

VTI1A

1.56

0.001

47

CHST7

carbohydrate (N-acetylglucosamino) sulfotransferase 7 (Chst7)

1.56

0.019

48

2010011I20RIK

RIKEN cDNA 2010011I20 gene (2010011I20Rik)

1.56

0.039

49

PCDHAC1

protocadherin alpha subfamily C, 1 (Pcdhac1)

1.55

0.025

50

4930503L19RIK

RIKEN cDNA 4930503L19 gene (4930503L19Rik) XM_001001515

1.55

0.046

51

HSPA12A

heat shock protein 12A (Hspa12a)

1.55

0.045

52

LOC100047052

PREDICTED: similar to Aptx protein (LOC100047052)

1.55

0.006

53

GALNT3

1.55

0.010

54

ALG8

1.54

0.012

1

LOC232065

2

CYFIP2

3

PHF14

4

5430417J04RIK

5

AU021092

6

Definition

asparagine-linked glycosylation 8 homolog (yeast, alpha-1,3-glucosyltransferase) (Alg8)

59

55

LOC235086

1.54

0.014

56

TTLL9

tubulin tyrosine ligase-like family, member 9 (Ttll9), transcript variant 1

1.54

0.043

57

PPP2R2C

protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform (Ppp2r2c)

1.54

0.018

58

ROBO1

roundabout homolog 1 (Drosophila) (Robo1)

1.53

0.048

59

ELFN2

leucine rich repeat and fibronectin type III, extracellular 2 (Elfn2)

1.53

0.020

60

EG406223

predicted gene, EG406223 (EG406223)

1.53

0.012

61

2210008F06RIK

PREDICTED: RIKEN cDNA 2210008F06 gene (2210008F06Rik)

1.53

0.039

62

PVRL3

poliovirus receptor-related 3 (Pvrl3), transcript variant alpha

1.53

0.044

63

RNF123

ring finger protein 123 (Rnf123)

1.53

0.000

64

5830435K17RIK

1.52

0.025

65

RTN4

reticulon 4 (Rtn4), transcript variant 1

1.52

0.016

66

SEMA3E

sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E (Sema3e)

1.52

0.018

67

PPP4R4

protein phosphatase 4, regulatory subunit 4 (Ppp4r4)

1.52

0.030

68

COVA1

cytosolic ovarian carcinoma antigen 1 (Cova1)

1.51

0.016

69

6030419L17RIK

1.51

0.003

70

POPDC3

popeye domain containing 3 (Popdc3)

1.51

0.049

71

XKR7

X Kell blood group precursor related family member 7 homolog (Xkr7)

1.51

0.031

72

CCDC94

coiled-coil domain containing 94 (Ccdc94)

1.51

0.024

73

E130309D02RIK

RIKEN cDNA E130309D02 gene (E130309D02Rik)

1.51

0.004

74

1700020L24RIK

RIKEN cDNA 1700020L24 gene (1700020L24Rik)

1.51

0.006

75

SGTB

small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta (Sgtb)

1.50

0.003

76

CHD5

chromodomain helicase DNA binding protein 5 (Chd5), transcript variant 1

1.50

0.012

77

RIC3

resistance to inhibitors of cholinesterase 3 homolog (C. elegans) (Ric3), transcript variant 2

1.50

0.019

78

KCNIP2

Kv channel-interacting protein 2 (Kcnip2), transcript variant a

1.50

0.008

79

NCKAP1

NCK-associated protein 1 (Nckap1)

1.50

0.017

80

GRHL1

grainyhead-like 1 (Drosophila) (Grhl1)

1.50

0.044

81

D030013I16RIK

RIKEN cDNA D030013I16 gene (D030013I16Rik)

1.49

0.005

82

ARL3

ADP-ribosylation factor-like 3 (Arl3)

1.49

0.032

83

PI15

peptidase inhibitor 15 (Pi15)

1.49

0.012

84

SNAP91

synaptosomal-associated protein 91 (Snap91)

1.49

0.017

85

SEZ6L2

seizure related 6 homolog like 2 (Sez6l2)

1.49

0.018

86

BC030500

cDNA sequence BC030500 (BC030500)

1.48

0.042

87

6030405A18

1.48

0.028

88

MCRS1

microspherule protein 1 (Mcrs1)

1.48

0.011

89

LAMA4

laminin, alpha 4 (Lama4)

1.48

0.026

90

GDA

guanine deaminase (Gda)

1.48

0.018

91

PARP1

poly (ADP-ribose) polymerase family, member 1 (Parp1)

1.48

0.004

92

MAPK8IP1

mitogen-activated protein kinase 8 interacting protein 1 (Mapk8ip1)

1.48

0.023

93

DLX2

distal-less homeobox 2 (Dlx2)

1.48

0.020

94

ISLR2

immunoglobulin superfamily containing leucine-rich repeat 2 (Islr2)

1.48

0.003

95

TGFB2

transforming growth factor, beta 2 (Tgfb2)

1.48

0.008

96

LOC100045726

PREDICTED: hypothetical protein LOC100045726 (LOC100045726)

1.48

0.009

97

9130213B05RIK

RIKEN cDNA 9130213B05 gene (9130213B05Rik)

1.48

0.041

98

NUFIP1

nuclear fragile X mental retardation protein interacting protein 1 (Nufip1)

1.47

0.022

99

CYB5D2

cytochrome b5 domain containing 2 (Cyb5d2)

1.47

0.005

ACO1

aconitase 1 (Aco1)

1.47

0.040

100

60

Table 2.S3 – Transcriptionally altered genes by microarray, WNV-good higher than
WNV-Poor. Genes higher in WNV-good than in WNV-poor (top 100 genes by fold change
and p value < 0.05)
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Pathway

p val

Altered genes

1

Primary immunodeficiency

6.3E-04

2

Cytokine-cytokine receptor interaction

9.3E-04

3

Natural killer cell mediated cytotoxicity

2.6E-03

4

Calcium signaling pathway

4.2E-03

5

Allograft rejection

5.4E-03

IGHG, TAP2, LCK, AIRE, IGH-VJ558
IFNAB, TNF, CCL2, TNFRSF12A, IL21R, IL11RA1,
TNFRSF4, CXCL10, CCL6, LEP, TNFRSF1A, FAS, IL1A
IFNAB, IGHG, CD244, TNF, ARAF, LCK, FAS,
KLRA3,
IGHG, EDNRB, PDE1C, TACR1, CAMK2D,
PLCD4, PLCD1, CHRNA7, CAMK2A, IGH-VJ558
LOC100048770, IGHG, TNF, H2-T10, FAS, H2-DMA,
IGH-VJ558

6

Graft-versus-host disease

5.4E-03

TNF, H2-T10, FAS, H2-DMA, IL1A, KLRA3

7

Apoptosis

7.1E-03

8

Autoimmune thyroid disease

1.3E-02

9

B cell receptor signaling pathway

2.0E-02

TNFRSF1A, IRAK3, TNF, NFKBIA, FAS, BIRC2, IL1A
IFNAB, LOC100048770, IGHG, H2-T10, FAS, H2-DMA,
IGH-VJ558
LOC100048770, IGHG, IFITM1, NFKBIA, PIK3AP1,
INPP5D, IGH-VJ558

10

Intestinal immune network for IgA
production

2.1E-02

11

Hematopoietic cell lineage

2.4E-02

LOC100048770, IGHG, LOC100048841, TNFSF13B,
H2-DMA, IGH-VJ558
LOC100048770, IGHG, TNF, ITGA1, IL11RA1, IL1A,
IGH-VJ558

12

Asthma

2.6E-02

LOC100048770, IGHG, TNF, H2-DMA, IGH-VJ558

13

NOD-like receptor signaling pathway

3.3E-02

TNF, CCL2, ERBB2IP, NFKBIA, BIRC2

14

Type I diabetes mellitus

3.5E-02

TNF, H2-T10, FAS, H2-DMA, IL1A

15

Adipocytokine signaling pathway

4.2E-02

LEP, TNFRSF1A, TNF, NFKBIA, CPT1A

Table 2.S4. Pathway analysis of genes significantly higher in WNV-poor spatial
memory performers compared to WNV-good at 25 days post-infection. KEGG
pathway analysis using DAVID bioinformatics database functional annotation tool v.6.7.
Analysis generated with list of genes having greater than 1.5 fold change and p value of
less than 0.05 in WNV-poor vs. WNV-good analysis. Adjusted p-values determined by
Benjamini false discovery rate.
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Pathway

p

Altered genes

1

Long-term potentiation

0.002

GRM5, GRIN2B, GRIN1, PPP3CA, PPP1CC, PPP1CB, PRKCB

2

Calcium signaling pathway

0.013

TRPC1, PHKB, PDE1A, CACNA1G, RYR2, PRKCB, CACNA1B

3

Axon guidance

0.014

EPHA5, SEMA6C, PLXNA4, ROCK2, ROBO1, SEMA3E, SLIT2

4

Wnt signaling pathway

0.027

TBL1XR1, CCND1, ROCK2, SIAH1B, SIAH1A, CUL1, PRKCB

5

Terpenoid backbone biosynthesis

0.030

LOC100040592, MVD, FDPS

6

MAPK signaling pathway

0.035

MAPT, CACNA1G, PLA2G6, FGF13, MAPK8IP1, TGFB2

7

Butanoate metabolism

0.036

LOC100040592, GAD1, PDHB, ALDH3A2

8

Glyoxylate and dicarboxylate metab.

0.039

GLYCTK, ACO1, AFMID

9

Steroid biosynthesis

0.043

TM7SF2, SQLE, SC4MOL

10

p53 signaling pathway

0.046

CCND1, SIAH1B, SIAH1A, CCNG2, ATM

Table 2.S5. Pathway analysis of genes significantly higher in WNV-good spatial
memory performers compared to WNV-poor at 25 days post-infection. KEGG
pathway analysis using DAVID bioinformatics database functional annotation tool v.6.7.
Analysis generated with list of genes having greater than 1.5 fold change and p value of
less than 0.05 in WNV-good vs. WNV-poor analysis. Adjusted p-values determined by
Benjamini false discovery rate.
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Group
WNV

Age
46
51

Sex PMI
f
f

15
22

WNV encephalitis

History of non-Hodgkin's lymphoma, bone-marrow transplant recipient

-

+++

-

-

WNV encephalitis

S. aureus infection, history of rheumatoid arthritis, lupus, and
immunosuppressive therapy

-

+++

-

-

-

+

-

+

DG CA2/3 CA1

EC

62

m

20

WNV encephalitis

75

m

?

WNV encephalitis

History of mantle cell lymphoma, bone-marrow transplant recipient

-

-

-

-

79

f

16

WNV encephalitis

Atherosclerosis, history of pyelonephritis, rheumatoid arthritis

-

-

-

-

Cause of
Death

Other findings / Comorbidities

Cardiac arrest

Emphysema, kidney atrophy, history of congestive heart failure, multiple
small vessel embolisms

-

-

-

-

Cardiogenic shock

Coronary artery disease, pericardial metastatic carcinoma, history of
hepatitis C, transplant recipient

-

-

-

-

Cardiac arrest

Atherosclerosis, history of prostate cancer, emphysema, hypertension

-

-

-

-

-

-

-

-

62.6

18.3

Group

Age

Sex PMI

47

f

21

56

f

15

57

m

4

DG

CA2/3 CA1

EC

60

m

17

Cardiac arrest

History of cardiac arrest, atherosclerosis, cardiomegaly,
emphysematous changes

60

f

12

Cardiac arrest

History of cerebral ischemic stroke (MCA), gram-negative sepsis

-

-

-

-

PEA cardiac arrest

Bronchopneumonia, chronic obstructive pulmonary disease, history of
myocardial infarction

-

-

-

-

PEA cardiac arrest

Atherosclerosis, history of congestive heart failure, history of
hypotension

-

-

-

-

Undetermined

Renal disease, myocyte hypertrophy, pulmonary fibrosis, history of
sepsis

-

-

-

-

65
72
84
Mean:

Other findings / Comorbidities

History of cardiac, lung, and brain sarcoidosis, cardiomegaly,
atherosclerosis, steroid treatment

Mean:

Control

Cause of
Death

62.6

m
m
f

17
25
39
18.8

Table 2.S6 – Human post-mortem tissue. Relevant information on human autopsy
cases used in this study, including age, sex, post-mortem interval (PMI) in hours, cause
of death, and other comorbidities noted. Abbreviations used: Pulseless electrical activity
(PEA), Dentate Gyrus (DG), Entorhinal Cortex (EC). Scoring = negative (-), mild (+),
moderate (++) or severe (+++) for West Nile virus antigen immunostaining.
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CHAPTER 3 – Alterations to hippocampal and subventricular zone adult
neurogenesis during West Nile virus encephalitis

Abstract
Cognitive sequelae have been reported to occur following the neuroinvasive
infections of several neurotropic viruses including Japanese Encephalitis virus 152, St.
Louis Encephalitis virus153, acute sporadic encephalitis caused by Herpes Simplex154, and
more recently, West Nile virus12,14,15. West Nile Virus (WNV) is a mosquito-borne flavivirus
capable of infecting and killing mature neurons and eliciting antiviral immune responses
throughout the central nervous system (CNS). In the United States, WNV has been
responsible for over 13,000 reported cases of encephalitis and meningitis since its
emergence in 1999. Of interest, over 50% of patients who recover from WNV
neuroinvasive disease (WNND) suffer cognitive sequelae, including confusion,
depression, and memory impairments for a year or longer beyond the course of acute
viral infection. Memory impairments and depression have both been linked to alterations
in adult neurogenesis, suggesting WNV impacts on this process. Previous studies by our
group, using a well-established murine model, have determined that chemoattractant
molecules expressed by WNV-infected neurons are responsible for recruiting
lymphocytes to promote viral clearance and survival40. Here we report that during WNND
recovery, significantly fewer new granule cell neurons are born within the hippocampal
dentate gyrus, as revealed by BrdU-labeling. And although neuronal progenitor cells
(NPCs) are not direct targets of WNV infection, their homeostatic levels of proliferation,
differentiation, and migration were significantly altered. Using immunohistochemistry and
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flow cytometry coupled with in vivo BrdU labeling during acute WNV infection, we found
NPCs within the subventricular (SVZ) and subgranular (SGZ) neurogenic zones
generated fewer new neuroblasts, but greater numbers of astrocytes, an effect which
slowly recovers over about 45 days. This effect was dependent upon Interleukin-1
receptor (IL-1R)

signaling, which we have previously shown to be necessary for

promotion of viral clearance by T lymphocytes10.

Lastly, IL-1R deficient mice were

resistant to the WNV-mediated impairment in spatial learning and memory observed in
wild type mice (Vasek and Klein, chapter 2) via the Barnes maze task at 45 days post
infection, suggesting that the alterations to neuronal progenitor cell homeostasis during
adult neurogenesis may underlie long term cognitive consequences of WNND.

Introduction
West Nile Virus (WNV) has recently experienced resurgence in the United States.
Both the number of total cases and the number of neuroinvasive cases more than
quadrupled in 2012 compared to 201111. In the acute stage of infection, patients suffering
from WNV encephalitis or meningitis can experience confusion, fatigue, loss of motor
control, memory loss, coma, and a mortality rate of about 8-10%12. Unfortunately, of the
many patients who survive neuroinvasive WNV, about half experience long term cognitive
sequelae including depression, memory impairments, and motor impairments for several
months to years beyond the episode of symptomatic infection14–16,97,126. To date, there
have been no published studies that investigate the mechanistic causes of long-term
cognitive sequelae or the extent of damage and repair that occurs beyond the acute
phase of WND.
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Once WNV has entered the central nervous system, it preferentially infects and
replicates within neurons and can cause apoptosis via caspase-3 induction20,21. A robust
encephalitic response follows CNS WNV infection, in which T cells are crucial for viral
clearance and survival37,38; however it is possible that this infiltration of leukocytes into
the CNS may cause additional neuron damage. Likely, the specific brain regions which
are variably infected by WNV might dictate the symptoms and sequelae experienced by
patients in the short and long-term, respectively. The hippocampus, an area often infected
in both human and murine WNV encephalitis19,155, is essential for spatial and contextual
memory formation. Inputs from the entorhinal cortex enter the hippocampus and relay
through the dentate gyrus, CA3, and CA198. Damage to hippocampal neurons or their
synaptic connections could restrict proper spatial memory formation or memory recall.
Another component of hippocampal learning involves the process of adult
neurogenesis, which occurs within the hippocampal dentate gyrus (DG) and the
subventricular zone (SVZ)156. Within the DG, adult neural stem cells give rise to
astrocytes and intermediate neuronal progenitors, the latter of which proliferate and
differentiate into neuroblasts. These neuroblasts migrate into the granule cell layer of the
DG, mature into granule cell neurons and integrate into the hippocampal circuit over the
course of a few weeks71,157. Although the precise extent to which adult neurogenesis
contributes to spatial learning is a field which needs further careful investigation, it is clear
that voluntary running and environmental enrichment increase neurogenesis as well as
performance in several spatial learning and memory tasks in rodents 158–160. Furthermore,
ablation of neurogenesis by X-ray irradiation leads to impaired spatial learning in the
Barnes Maze72. The fact that many WNND patients experience memory impairments for
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months to years beyond viral clearance suggests a chronic condition with either sustained
damage or limited repair.
The inflammatory cytokine Interleukin 1 (IL-1), which has two main forms, IL-1α
and IL-1β, has also been shown to impact on cognitive function in the context of
neuroinflammation. While IL-1 is known to be a key player in orchestrating the CNS
immune response, including onset of fever161, it also plays a role in spatial learning and
memory-related behavior162. Indeed, injection of IL-1β into the brain impairs spatial
learning, contextual fear memory, and adult neurogenesis163–165. Of interest, IL-1Rdeficient mice are slow to learn the Morris water maze task, display a deficit in long-term
potentiation in the hippocampus, and exhibit longer freezing times during contextual fear
memory testing166,167. Although several studies have investigated impacts of IL-1 on
hippocampal-based learning and behavior, few have done so in a setting of physiological
IL-1 induction, such as during CNS infection.
In this study we utilize a previously described murine model of WNND recovery
replete with spatial memory impairments out to 50 days post-infection (Chapter 2).
Utilizing a brdU pulse-chase experiment, we show that adult WNV-recovered mice
experience a loss in newborn dentate granule cell neurons during the period of spatial
learning and memory impairments. Using flow cytometry, we were able to show that this
neuronal loss is due to a reduction in the proliferation/differentiation of neural progenitors
along the neuronal lineage during the acute phase of WNV infection, which lasts out to at
least 30 days post-infection. Interestingly, neuronal progenitors within the SVZ suffered a
similar reduction in neuroblast proliferation during WNND, as well as an additional
aberration in their migratory patterns. Wild type mice infected and recovered from WNV-
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NS5-E218A infection displaying impaired spatial learning and memory were found to have
upregulated transcripts relating to IL-1R signaling. Furthermore, IL-1R -/- mice did not
experience the WNV-mediated alterations to neuronal progenitor cell proliferation and
importantly, also did not show a WNV-mediated impairment to spatial learning and
memory in the Barnes Maze task. This study highlights a potential pathway and
mechanism underlying impairments to memory during WNND.

Results and Discussion
To better understand the cognitive sequelae experienced by many patients who
have recovered from WNV encephalitis we established a murine model of WNV recovery
to study cognitive impairments. Because footpad infection with wildtype WNV (WNV-NY)
leads to variable levels of CNS infection and direct intracranial infection with WNV-NY
virus is 100% lethal, we intracranially inoculated mice with 104 pfu of an attenuated mutant
form of WNV (2’O methyltransferase-E218A)9,168. The mutant WNV-E218A does infect
neurons when administered via this route, replicates within the CNS, and induces an
antiviral encephalitic response, however over 90% of mice survive and recover from the
encephalitis. Intracranial (i.c.) infection with WNV-E218A is capable of infecting all brain
regions infected by WNV-NY including the hippocampus, cortex, striatum, cerebellum,
and brainstem and capable of inducing neuronal apoptosis9.
Because the process of adult neurogenesis contributes to hippocampal spatial
learning and memory71, we evaluated the generation of new neurons during WNV
encephalitis and the recovery period. We administered BrdU during the peak of WNV
encephalitis for a period of 4 days (days 3-7), and then allowed mice to recover for 52
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days. WNV-recovered mice exhibited fewer BrdU-labeled neurons within the dentate
gyrus granule cell layer than mock-infected controls (Fig. 3.1).
One possible explanation of fewer new neurons after the recovery period of WNV
encephalitis is that neuroblasts are dying before reaching maturity. In agreement with
previous studies, we confirmed that neural stem cells and intermediate neuronal
progenitors were not permissive to WNV infection128, and observed that less than 1% of
doublecortin-expressing neuroblasts were infected in vivo in both the SVZ and SGZ (Fig.
3.2). Furthermore rates of neuroblast apoptosis during acute WNND were equivalent to
mock-infected controls (data not shown). The few infected neuroblasts which were
observed within the DG were located within the granule cell layer, suggesting that these
may be late-stage neuroblasts as they are transitioning into immature neurons. Latestage neuroblasts exhibit many of the same properties as neurons including, receptors,
filament proteins, and cellular processes (e.g. axon formation and the beginning of
dendrite formation), thus potentially explaining the ability of WNV to infect them.
Another explanation for reduced neurogenesis includes the alteration in the rate of
neuronal progenitor cell proliferation. To test this, mock-infected versus WNV-NY-infected
or WNV-E218A-infected mice were administered BrdU during the peak of encephalitis,
followed by either immunohistochemical (Fig. 3.3a) or flow cytometric (Fig. 3.3b)
evaluation of hippocampal neuronal progenitors, as described previously149. Infections
with either wild type WNV (NY-99) via the peripheral footpad route (Fig. 3.3a), via the
intracranial infection route, or attenuated WNV-NS5-E218A all led to fewer BrdU-labeled
neuroblasts at 6-8 days post-infection (Fig. 3.3b). This reduction in neuroblast-genesis
was assessed over the course of WNND recovery, at 6, 15, and 30 days post-infection
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(after normalization to age-matched controls) and found that deficits persist until at least
day 15 within the hippocampus and day 30 within the SVZ (Fig. 3.3c).
Alterations in the proliferation rates of neural progenitors could result in changes
to the overall pool of stem cells over time. Using-GFP-expressing mice, we counted the
numbers of Nestin and GFAP-double positive cells remaining within the hippocampal
SGZ at 45 days post-infection, but found no differences in the numbers of neural stem
cells expressed by mock and WNV-NS5-E218A recovered mice (data not shown).
To further investigate the potential for an alteration in cell fate / differentiation of
early stage progenitors, we tested to see if fewer neuronal progenitors were produced in
favor of more glial progenitors within the hippocampus of WNV-infected mice. To test this,
mock-infected versus WNV-NY-infected or WNV-E218A-infected mice were administered
BrdU during the peak of encephalitis followed by flow cytometric evaluation of
hippocampal neuronal progenitors and astrocytes 48 hours later (Fig. 3.4). Infections with
either wild type WNV (NY-99) or attenuated WNV-NS5-E218A led to more BrdU-labeled
gfap-expressing astrocytes at 7 days post infection than mock-infected controls (Fig. 3.4).
The migration of neuroblasts to their proper targets remains an additional important
component of functional adult neurogenesis71. Upon examining neuroblasts within the
SVZ from WNV-infected mice, we additionally discovered an abberant migration pattern
expressed by these cells, in that more DCX+ cells were found at distances greater than
30 microns from the walls of the lateral ventricle (Fig. 3.5). This phenomenon has
previously been observed in striatal ischemic models169, but has not been previously
described in viral models of CNS infection.
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Since adult neural stem cells within the DG can give rise to both the astrocyte and
neuronal lineages in vivo170, our results suggest that there is either a reduction in
proliferation of neuronal progenitors in combination with an increase in proliferation of
astrocyte progenitors, or there is a shift in the differentiation of neural stem cells, causing
more daughter cells to enter the astrocyte lineage in favor of the neuronal lineage. The
cytokines, Interleukin-1α (IL-1α) and Interleukin-1β (IL-1β), have been shown to induce
neural stem and progenitor cells in vitro to favor the astrocyte rather than neuronal
lineage171. Furthermore, two members of the IL-1 receptor (IL-1R) signaling pathway,
Caspase-1, which cleaves and activates IL-1β, and IL-1α, were identified by a microarray
screen in chapter 2 as being highly expressed in mice with sever spatial memory
impairments during WNND. In additional cohorts of wild-type mice, we validated this
microarray by quantitative PCR and found significant hippocampal upregulation of both
genes specifically within the WNV-poor spatial memory performing mice compared to
mock-infected controls (Fig. 3.6).
Next, we tested if the WNV-mediated reduction in neuroblast proliferation would
occur in mice lacking IL-1 signaling utilizing IL-1R -/- mice. Mock-infected and WNV-NS5E218A-infected IL-1R -/- mice were administered BrdU during the peak of encephalitis,
followed by flow cytometric evaluation of hippocampal neuronal progenitors. In contrast
to the reduction in neuroblast genesis observed in wild type animals, IL-1R -/- were
resistant to changes in neuroblast proliferation rates (Fig 3.7).
If reductions to neurogenesis was underlying the spatial memory impairments
exhibited by WNND recovering mice (Fig 2.1a), then it might be expected that IL-1R -/mice recovering WNND may exhibit preservation of spatial learning and memory. Thus,
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after i.c. infection with WNV-NS5-E218A, we allowed IL-1R -/- mice to recover for a month
beyond viral clearance (46 days post infection) and tested their ability to spatially locate
and remember the location of a target hole in a Barnes maze over the course of 10 trials
held twice daily for 5 days. In contrast to wild type mice, IL-1R -/- mice recovering from
WNND performed equally well on the Barnes Maze spatial learning task (Fig. 3.8).
One significant caveat to the experiments utilizing IL-1R -/- mice is that in other
spatial learning tasks (e.g. morris water maze), IL-1R -/- mice have altered baseline
spatial memory performance than wild type mice and it is possible that the same
pathway(s) which becomes impaired during WNND recovery of wild type animals is
already impaired in adult IL-1R -/- animals. Experiments with IL-1R pathway antagonists
performed in wild type mice may be warranted to confirm the aforementioned results.
Taken together, our results show that during the acute phase of viral infection, the
proliferation, migration, and differentiation fates of neural progenitor cells are altered
during the recovery period of WNV encephalitis. Interestingly, mice deficient in IL-1R
signaling are resistant to both the altered npc proliferation as well as spatial memory
impairments which are observed in wild type WNND mice. The combinatorial effect of
synapse loss (chapter 2) and reduced neurogenesis (chapter 3) is likely to seriously
impact hippocampal spatial learning and memory long beyond the initial episode of
infection.

Materials and methods
Animals
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5-8 week-old male mice were used at the outset of all experiments. C57BL/6J mice were
obtained from Jackson Laboratories. IL-1R -/- mice (> 10 generations backcrossed to
C57Bl/6) were obtained from Jackson Laboratories. Nestin-GFP mice (> 10 generations
backcrossed to C57Bl/6) were obtained from Dr. Gregory Enikolopov (Cold Spring Harbor
Laboratories). All experimental protocols were performed in compliance with the
Washington University School of Medicine Animal Safety Committee (protocol#
20140122).

Mouse models of WNV infection
Footpad: (WNV-NY99) The WNV strain 3000.0259 was isolated in New York in 2000
(Ebel et al., 2001) and passaged once in C6/36 Aedes albopictus cells to generate an
insect cell–derived stock. 100 plaque forming units (pfu) of WNV-NY99 were delivered in
50 uL to the footpad of anaesthetized mice.

Intracranial: “WNV-NS5-E218A,” which harbors a single point mutation in the 2’O-methyltransferase gene, was obtained from Dr. Michael Diamond (Washington University) and
passaged in vero cells as described previously8. Deeply anaesthetized mice were
administered 104 pfu of WNV-NS5-E218A or 10 pfu of WNV-NY99 in 10 uL into the brain’s
third ventricle via a guided 29 gauge needle.

Stock titers of all viruses were determined by using BHK21 cells for viral plaque assay as
previously described103.
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Antibodies
WNV (1:100 described previously10), GFAP (1:200 Invitrogen), Doublecortin (1:150 Cell
Signaling), BrdU (1:50 for flow cytometry BD Biosciences), BrdU (1:200 for IHC Abcam)
NeuN-biotin (1:100 Millipore), GFP (1:1000 Abcam),

Secondary antibodies conjugated to Alexa-488, Alexa-555, or Alexa-647 (Invitrogen)
were used at 1:400 dilution.

Immunohistochemistry
Following perfusion with ice-cold PBS and 4% PFA, brains were immersion-fixed
overnight in 4% PFA, followed by cryoprotection in 2 exchanges of 30% sucrose for 72
hours, then frozen in OCT (Fisher). 9µm-thick fixed-frozen coronal brain sections were
washed with PBS and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich), and
nonspecific Ab was blocked with 5-10% normal goat serum (Santa Cruz Biotechnology)
for 1 h at room temperature. Mouse on Mouse kit (MOM basic kit, Vector) was used per
manufacturers protocol when detecting synaptophysin (mouse, DAKO) to reduce
endogenous mouse Ab staining. After block, slides were exposed to primary Ab or isotype
matched IgG overnight at 4°C, washed with 0.2% FSG in PBS and incubated with
secondary Abs for 1 h at room temperature. Nuclei were counterstained with ToPro3
(Invitrogen) and coverslips were applied with vectashield (Vector). Immunofluorescence
was analyzed using a Zeiss LSM 510 laser-scanning confocal microscope and
accompanying software (Zeiss). Positive immunofluorescent signals were quantified
using the public domain NIH Image analysis software, ImageJ.
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TUNEL staining was performed using the TMR-red in situ cell death detection kit (Roche)
as per manufacturer’s instructions. C1qA staining was performed as previously
described147.

Flow cytometry
Cells were isolated from brains of WT mice at day 6, 15, or 30 days post-infection and
stained with fluorescently conjugated antibodies to CD45, BrdU, and Doublecortin as
previously described149. Data collection and analysis were performed with an LSRII flow
cytometer using FlowJo software.

Real-time quantitative RT-PCR
cDNA was synthesized using random hexamers, oligodT15, and MultiScribe reverse
transcriptase (Applied Biosystems). A single reverse transcription master mix was used
to reverse transcribe all samples in order to minimize differences in reverse transcription
efficiency. The following conditions were used for reverse transcription: 25°C for 10 min,
48°C for 30 min, and 95°C for 5 min.

Behavioral Testing
The Barnes Maze was used to assess for visual spatial memory. An elevated Barnes
Maze (36” diameter, custom built) containing 19 empty holes and 1 target hole with a
hidden escape chamber was used for testing (2” diameter holes were evenly spaced
around the table, 2.5” from the edge). Visual cues were placed around the room and
remained in the same location during the entire testing period. Mice were tested on the
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Barnes Maze over the course of 5 consecutive days. Each mouse received two trials per
day, spaced exactly 30 minutes apart. For each trial, the mouse was placed in the center
of the maze in a covered start box for 10 seconds, and removal of the box signaled the
start of a trial. Each mouse was given 3 minutes to explore the maze and find the target
hole. Mice that did not enter the target hole within 3 minutes were gently guided into the
hole. After each trial, the mouse remained in the target hole for exactly 1 minute, and then
was returned to its home cage. The maze was decontaminated with 70% ethanol between
each trial. The numbers of errors (nose pokes over non-target holes) and the latency to
find the target hole (amount of time elapsed before nose poke over target hole) were
measured. Behavior was recorded using a camera (Canon Powershot SD1100IS), and a
blinded experimenter scored the trials.
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Figures and Tables

Fig 3.1. Fewer new neurons are born within the dentate gyrus during WNV-NS5E218A recovery. Mice were given an I.P. BrdU injection (75 mg/kg) every 12 hours for
3.5 days (7 injections) beginning at day 4 pi, then we waited until 52 days post-infection
to sacrifice mice for immunohistochemistry analysis. Cells born during the period of BrdU
labeling are labeled with anti-BrdU (red) and neurons are labeled with NeuN (green),
nuclei are labeled with Dapi (blue). Right: The number of BrdU+ NeuN+ cells per section
of dentate gyrus were quantified and normalized to percent of mock-infected control. * p
< 0.05 by student’s t-test. > 4 sections per animal analyzed
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Fig 3.2 WNV Permissivity within Doublecortin-positive neuroblasts in vivo. 5 week
old mice were infected via the footpad with 100 pfu of wild type WNV(NY99) and
harvested for tissue collection on day 8 post infection. Immunohistochemistry is shown
for West Nile antigen and the neuroblast marker, doublecortin (DCX) within the Dentate
gyrus and Subventricular Zones (SVZ). Many WNV+ neurons can be seen within the
granule cell layer (GCL) of the Dentate gyrus and the striatum neighboring the SVZ,
however only 1 out of 4 animals showed any WNV and DCX-double positive cells (shown
by white arrowhead, Left), resulting in a mean % of infection of less than 1% of total DCX+
cells. Within the Dentate gyrus, infected DCX+ cells were always located within the GCL
– indicating that they are more mature neuroblasts or immature neurons.
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Fig 3.3 Deficits in adult neurogenesis during WNV infection.
Mice were given an i.p. BrdU injection (100 mg/kg) at 24 and 48 hours prior to harvest.
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A) Immunohistochemistry shows fewer BrdU-labeled neuroblasts, marked by the marker,
Doublecortin (DCX), within the SVZ at 8 days post-infection with WNV-NY via the footpad
(100 pfu) compared to uninfected age-matched controls. B) The proliferation rates of
neuroblasts were measured (% BrdU incorporation) within subventricular zone (SVZ) or
hippocampus (HP) dissections from mice, and isolation of cells for flow cytometry. Shown
are graphs of BrdU+ cells after gating on doublecortin+ cells at 6 days post intracranial
infection with either wild type WNV-NY99, WNV-NS5-E218A, or saline (Mock). C) The
proliferation rates of neuroblasts were measured by % of neuroblasts with BrdU
incorporation using flow cytometry after gating on doublecortin+ cells at 6, 15, and 30
days post WNV-NS5-E218A or mock infection. All data in (C) normalized to age-matched
mock-infected controls to compensate for age-related alterations in neurogenesis.
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Fig 3.4. Greater numbers of BrdU-labeled astrocytes neurons are born within the
hippocampus during acute WNV encephalitis. Mice were given an i.p. BrdU injection
(100 mg/kg) at 24 and 48 hours prior to harvest on day 6 pi. Left: Isolation of GFAP+
astrocytes and DCX+ neuroblasts by flow cytometry. Right: Percentage of GFAP+
astrocytes labeled with BrdU at day 6 post intracranial WNV-NY or WNV-E218A infection.
** p < 0.01 by Two-tailed Student’s T-test.

82

Fig 3.5 Aberrant migration of SVZ neuroblasts during WNV infection. Age and sexmatched uninfected mice or mice infected via the footpad with 100 pfu of WNV-NY (1999),
were collected at 8 days post infection. Following immunohistochemichal staining for the
neuroblast marker, Doublecortin (DCX), the number of DCX+ cells found greater than 30
microns (depicted by white arrowheads) from the lateral ventricle wall were calculated. **
p < 0.01 by Two-tailed Student’s T-test.
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Fig 3.6 Gene transcripts in the IL-1R signaling pathway are altered specifically in
WNV-NS5-E218A-infected poor spatial learning mice. RNA from hippocampi was
collected at day 25 post-infection from Mock, and WNV-NS5-E218A infected, recovering
mice which exhibited good or poor spatial memory on the Barnes Maze task. NS = not
significant, # = trend towards significance (0.10 > p > 0.05), *** = p < 0.001 by Two-tailed
Student’s T-test.
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Fig 3.7 IL-1R -/- mice are resistant to WNV-mediated alterations to neuroblast
proliferation. The proliferation rates of neuroblasts were measured (% BrdU
incorporation) within subventricular zone or hippocampus following dissection and
isolation of cells for flow cytometry. Shown are graphs of % of BrdU+ cells after gating on
doublecortin+ cells at 6 days post intracranial infection with WNV-NS5-E218A, or saline
(Mock) and normalization against genotype and age-matched mock-infected controls. **
p < 0.01, *** p < 0.001 by Two-tailed student’s T-test.
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Fig 3.8 IL-1R -/- WNV-E218A-infected mice do not harbor significant differences in
spatial learning and memory via the Barnes Maze behavior task. Mice were infected
with 104 pfu of WNV-NS5-E218A at 8 weeks of age and allowed to recover for 45 days
before the initiation of Barnes Maze testing. Number of errors (nose poke in non-target
hole) committed before finding the target hole in the Barnes Maze were measured twice
per day and averaged, with an inter-trial interval of 30 minutes, over the course of 5 days
of testing. Statistics: not significant by repeated measures two-way ANOVA.
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Fig 3.S1. Flow Cytometry gating strategy. A) Following isolation and staining with Dapi
and antibodies to CD45, Doublecortin, and BrdU, doublets were excluded, and the CD45negative population was utilized for further gates. B) Percentage of BrdU+ neuroblasts,
through expression of the marker, DCX, was calculated and example plots shown from
Hippocampus (HPC), Hippocampus from an animal which did not receive BrdU injection
(HPC no BrdU), Cortex (CTX), and Subventricular Zone (SVZ).
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CHAPTER 4 – Conclusions and Future Directions

Conclusions
Within the introduction, I discussed critical roles that molecular pathways utilized
by the immune system in pathogen defense can also contribute to normal (healthy) CNS
development. This idea formed the basis for the development and characterization of a
murine WNND recovery model, in order to study how CNS inflammatory processes during
WNND may contribute to the cognitive impairments experienced by WNND survivors –
and specifically to spatial learning and memory, which is well-modeled by murine
behavioral studies.
Two pathways have been highlighted in previous chapters of this thesis, the role
of classical complement and microglia in synaptic maintenance through synaptic pruning,
and the role of cytokines, especially Interleukin-1 signaling, in regulation of neuronal
progenitor cell proliferation and fate. And although these pathways clearly represent
pathways with effects on spatial learning and memory in these contexts, additional genes
and pathways likely play important roles as well, as is suggested by the several hundred
altered genes identified in our microarray experiment within chapter 2 (Figure 2.2).
In chapter 2 we investigated the role of microglia and classical complementmediated synaptic pruning during WNND on cognitive function. Using a novel murine
model to study memory impairments during recovery from WNND, we showed that mice
exhibit spatial learning and memory deficits during recovery and robust microglial
activation during the acute phase that persists for nearly two months post-WNV infection.
Using electron and confocal microscopy, we demonstrate that these activated microglia
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phagocytize synapses during the peak of WNV infection, leading to a significant loss of
synapses in the hippocampus and entorhinal cortex. Using whole transcriptome array
approaches we identified genes and pathways associated with poor spatial learning,
including molecules involved in microglial- and complement-mediated phagocytosis of
synapses. Consistent with these data, we observed upregulation of complement protein
C1q within neurons and microglia and showed that CA3 synapse elimination is abolished
in mice deficient in either microglia or complement C3. Moreover, we detected
significantly reduced numbers of hippocampal CA3 synapses in post-mortem human
specimens of WNV encephalitis compared with age- and sex-matched controls,
highlighting the relevancy of our murine model for human infections with WNV.
This study was the first to show synapse elimination as a pathological feature of
WNV encephalitis and to delineate mechanisms that underlie synapse elimination. While
the classical complement pathway may, at first glance, represent an intriguing therapeutic
target for WNND survivors, this avenue must be examined with caution, as many offtarget effects, such as increased susceptibility to further infections could result. A more
intriguing therapeutic target would include the identification of a component of this
pathway specifically expressed by microglia, but absent within the periphery. Even in this
case, the consequences of altering homeostatic synaptic pruning have not yet been
studied.
In chapter 3 we showed that during the acute phase of viral infection, the
proliferation, migration, and differentiation fates of neural progenitor cells are altered
despite not being direct targets of WNV infection. Of interest, mice deficient in IL-1R
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signaling were resistant to both the altered progenitor cell proliferation as well as spatial
memory impairments which are observed in wild type WNND recovering mice.
Of interest, there are documented studies linking alterations in network excitability
of the hippocampal circuit and resulting feedback from GABAergic interneurons to
regulation of adult neurogenesis172,173. Furthermore, the specific synapses studied within
chapter 2 were the axon terminals between the dentate gyrus and CA3 pyramidal
neurons, some of which are derived from adult-born granule cell neurons of the dentate
gyrus. The combinatorial effect of synapse loss, identified within chapter 2, and reduced
neurogenesis, identified within chapter 3, is likely to seriously impact hippocampal spatial
learning and memory long beyond the initial episode of infection.

Future Directions
Determine if the classical complement cascade prevents transsynaptic spread of
neurotropic viruses
In Chapter 2, I discussed how in response to WNV infection, the classical
complement cascade is upregulated, leading to the pruning of synapses by microglia. A
speculative hypothesis is that this process has evolved as a way for virus-infected
neurons to be recognized and disconnected from the local neural circuit in order to limit
both transsynaptic viral spread, as is achieved by rabies virus and herpes simplex virus
type 1, as well as any aberrant or excitotoxic signaling originating from the infected
neuron. It would be interesting to test if in the absence of a functional complement
cascade, for example in mice null for complement C3, if either WNV or a virus known to
traffic transsynaptically, such as HSV-1 is able to spread more quickly. Though it would
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be most compelling to show this effect in vivo, perhaps a simpler and easier to quantify
system to use might include a hippocampal ex vivo slice preparation or with primary
neurons plated in a campenot chamber in coculture with microglia as has been
described174. In either setup, viral infection would be done (a GFP reporter particle would
work best for in vitro studies) within specific neurons of a slice preparation or within one
side of the campenot chamber, followed by measurements of viral spread to connecting
neurons either in the presence of complement inhibitors or within microglia and neurons
from complement deficient mice.

Determine if MHC Class I pathway contributes to disruptions in spatial learning and
memory during WNV recovery
In Chapter 2 we performed a microarray experiment to search for candidate genes
and pathways involved in spatial learning and memory defects in WNV-infected and
recovering mice. One gene pathway which was identified in our screen, but have yet to
follow-up with further experiments, is the MHC Class I pathway. This pathway is famously
known for its role in the immune response in displaying non-self peptides at the cell
surface for recognition by lymphocytes52. More recently, the MHC class I pathway has
been shown to be instrumental in setting up neuronal connections and enhancing
plasticity within the brain during development55,56. The following genes within the MHCI
pathway were found to be altered specifically within poor spatial learning and memory
WNV-infected and recovered mice: TAPBP, PSMB8, H2-DMA, H2-T10, HMHA1. Further
investigation using transgenic and knockout mice might yield insights into how induction
of this pathway during CNS infection may impact correlates of learning and memory.
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Additional gene transcripts altered in WNV-poor learners with known effects on
neurons and neural connections include, Sema6c and Sema3e175, ROBO1, Sema3F176.
These molecules represent additional targets which could be further investigated.

Determine if IL-1R antagonism in wild type mice rescues spatial learning and memory
during WNV recovery
Since it is known that IL-1R -/- mice exhibit baseline (naïve animals) differences to
both spatial learning and memory and neurogenesis, a better test to determine the role
of IL-1R signaling is to do so in the absence of any developmental abnormalities, in wild
type mice. To do so, IL-1RA (IL-1 receptor antagonist) could be administered peripherally
(high dose) or via the lateral ventricle. The timing of this administration would have to be
determined using pilot studies, since our group has previously reported that IL-1R
signaling is crucial to proper T cell priming and viral clearance10 – thus the therapy should
probably begin at approximately 12-15 days post-infection, a point in time when virus is
on the decline and T cells have already received priming. Mice would then be tested on
the Barnes Maze spatial memory task at days 46-50 post-infection as has been previously
described.

Determine if the WNV-mediated reduction in neurogenesis is due to direct infection, PRR
recognition by NPCs, or a more global cytokine effect
Two experiments could be performed to address this question. First, the incubation
of neurosphere-derived neuronal progenitors could be incubated with WNV in vitro, and
pulsed with BrdU in the media. Rates of division would be measured in the setting of WNV
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or PBS (control) conditions. The second experiment would involve injecting ultravioletkilled WNV intracranially, and measuring rates of neuroblast proliferation as was done
previously (Chapter 3). If UV-killed WNV induces similar deficits in neurogenesis, this
would suggest a more global, pattern recognition receptor-mediated induction of
cytokines which impacts on the process of adult neurogenesis. If UV-killed WNV fails to
induce an alteration in proliferation, then the experiment is less conclusive and could
indicate either a certain threshold of infection necessary to elicit the neurogenic
alterations or that live, replicating virus is necessary for the response.
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